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Résumé 
Le récepteur nucléaire Nr5a2, également connu sous le nom de liver receptor 
homolog-1 (Lrh-1), est exprimé au niveau de l’ovaire chez la souris, exclusivement dans les 
cellules lutéales et de la granulosa. La perturbation de Nr5a2, spécifique aux cellules de la 
granulosa chez la souris à partir des follicules primaires dans la trajectoire du 
développement folliculaire a démontré que Nr5a2 est un régulateur clé de l’ovulation et de 
la fertilité chez la femelle. Notre hypothèse veut que Nr5a2 régule les évènements péri- et 
post-ovulatoires dans une séquence temporelle lors de la folliculogénèse. Afin d'étudier 
l’implication de Nr5a2 lors de l’ovulation et de la lutéinisation à différents stades du 
développement folliculaire, nous avons généré deux modèles de souris knockout 
spécifiques aux cellules de la granulosa pour Nr5a2: 1) Nr5a2Amhr2-/-, avec une réduction de 
Nr5a2 à partir des follicules primaires et subséquents; 2) Nr5a2Cyp19-/-, avec une réduction 
de Nr5a2 débutant au stade antral de développement en progressant. L’absence de Nr5a2 à 
partir des follicules antraux a résulté en une infertilité chez les femelles Nr5a2Cyp19-/-, de 
même qu’en des structures non-fonctionnelles similaires aux structures lutéales au niveau 
des ovaires, en une réduction des niveaux de progestérone synthétisée ainsi qu’en un échec 
dans le support d’une pseudo-gestation. La synthèse de progestérone a été entravée suite à 
l’absence de Nr5a2 par l’entremise d’une régulation à la baisse des gènes reliés au transport 
du cholestérol, Scarb1, StAR et Ldlr, démontré par qPCR. Les complexes cumulus-oocytes 
des femelles Nr5a2Cyp19-/- immatures super-stimulées ont subi une expansion in vivo, mais 
l’ovulation a été perturbée, possiblement par une régulation à la baisse du gène du récepteur 
de la progestérone (Pgr). Un essai d’expansion du cumulus in vitro a démontré une 
expansion défectueuse du cumulus chez les Nr5a2Amhr2-/-, associée à un dérèglement de la 
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protéine des jonctions communicantes (Gja1; Cx43). Cependant, l’expansion du cumulus 
chez les Nr5a2Cyp19-/- n’a pas été autant affectée. Des résultats obtenus par qPCR ont 
démontré une régulation à la baisse dans l’expression des gènes Areg, Ereg, Btc et Tnfaip6 
chez les deux modèles de cellules ovariennes knockout à 2h et 4h post hCG. Nous avons 
observé que 85% des oocytes, chez les deux génotypes mutants, peuvent subir une rupture 
de la vésicule germinative, confirmant leur capacité de maturation in vivo. La technique 
d’injection intra-cytoplasmique de spermatozoïdes a prouvé que les oocytes des deux 
génotypes mutants sont fertilisables et que 70% des embryons résultants ont poursuivi leur 
développement vers le stade de blastocyste, et ce, indépendamment du génotype. En 
conclusion, Nr5a2 régule la fertilité chez les femelles tout au long du processus du 
développement folliculaire. Il a été démontré que Nr5a2 est essentiel à la lutéinisation et 
que sa perturbation dans les cellules somatiques ovariennes ne compromet pas la capacité 
des oocytes à être fertilisés. En vue d’ensemble, nous avons fourni une investigation inédite 
et complète, utilisant de multiples modèles et techniques afin de déterminer les mécanismes 
par lesquels Nr5a2 régule les importants processus que sont l’expansion du cumulus, 
l’ovulation ainsi que la formation du corps jaune. 
 
Mots-clés: Nr5a2, cellules de la granulosa, expansion du cumulus, lutéinisation, 
fertilisation, souris knockout conditionnel 
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Abstract 
The nuclear receptor Nr5a2, also known as liver receptor homolog-1 (Lrh-1), is 
expressed in the mouse ovary, exclusively in granulosa and luteal cells. Granulosa-specific 
disruption of Nr5a2 in mice from primary follicles onward in the follicle development 
trajectory has shown that Nr5a2 is a key regulator of ovulation and female fertility. We 
hypothesized that Nr5a2 modulates peri- and post-ovulatory events in a temporal sequence 
during folliculogenesis. To examine the role of Nr5a2 in ovulation and luteinization at 
different stages of the follicular development, we generated two Nr5a2 granulosa-specific 
knockout mice models: 1) Nr5a2Amhr2-/-, with Nr5a2 depletion from primary follicles 
forward; and 2) Nr5a2Cyp19-/-, with Nr5a2 depletion from the antral stage of development 
forward. The lack of Nr5a2 beginning in antral follicles resulted in infertility in   
Nr5a2Cyp19-/- females, with ovaries displaying non-functional luteal-like structures, 
synthesizing reduced progesterone levels and failing in supporting pseudopregnancy. 
Progesterone synthesis was affected by the lack of Nr5a2 through the downregulation of the 
cholesterol transport-related genes, Scarb1, StAR and Ldlr, as shown by qPCR. The 
cumulus-oocyte complexes of superstimulated Nr5a2Cyp19-/- immature females underwent 
expansion in vivo, but ovulation was disrupted, likely due to the downregulation of the 
progesterone receptor (Pgr) gene. An in vitro cumulus expansion assay showed defective 
cumulus expansion in Nr5a2Amhr2-/- associated with a dysregulation in the gap junction 
alpha-1 (Gja1; Cx43). In vitro cumulus expansion in Nr5a2Cyp19-/- was less affected than in 
Nr5a2Amhr2-/- cumulus-oocyte complexes. Data from qPCR showed a downregulation in the 
gene expression of Areg, Ereg, Btc and Tnfaip6 in both knockout ovarian cells at 2 h and 4 
h post hCG. We found that 85% of the oocytes in both mutant genotypes can undergo 
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germinal vesicle breakdown, confirming their capability to mature in vivo. Intracytoplasmic 
sperm injection (ICSI) showed the oocytes in both mutant models to be fertilizable and 
70% of the resulting embryos proceeded to a blastocyst stage, independent of the genotype. 
In conclusion, Nr5a2 regulates female fertility along the entire process of the follicular 
development. Nr5a2 is shown to be essential for luteinization and its disruption in ovarian 
somatic cells does not compromise oocyte fertilizability. In overview, we provided a novel 
and comprehensive investigation, using multiple models and techniques to determine the 
mechanisms by which Nr5a2 regulates the important processes of cumulus expansion, 
ovulation and formation of the corpus luteum.  
 
Keywords: Nr5a2, granulosa cells, cumulus expansion, luteinization, fertilization, 
conditional knockout mouse 
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1 
Introduction 
Reproduction is an essential event of life, so much so that all the living organisms 
are the result of some form of reproductive phenomenon. In vertebrates, the natural 
generation of a new individual mandatorily requires the fertilization of the female gamete, 
or oocyte, by the male gamete, the spermatozoon. In the female reproductive system, the 
ovaries have a pivotal role in releasing the oocytes throughout the female reproductive 
life26. 
The ovaries are basically composed of ovarian follicles in different stages of 
development, including primary, secondary and antral follicles90. During the process of the 
follicular maturation, known as folliculogenesis, the interactions between the somatic cells 
of the ovary permit the growth and development of the oocyte114. A complex and 
fascinating synchrony of endocrine, biochemical and genetic events regulates the somatic 
cells of the ovary, including the theca, granulosa and cumulus cells97.  
The cumulus cells surround the oocyte in antral follicles, and these cells are 
important both prior to and after ovulation. The surge of luteinizing hormone (LH), 
produced by the pituitary gland, initiates the ovulatory process, stimulating the expansion 
of the cumulus cells in mature ovarian follicles, culminating in the release of the oocyte 
into the oviduct97. After ovulation, a series of changes remodels the follicle into the corpus 
luteum, comprised of reorganized theca and granulosa cells, and responsible for secreting 
progesterone79. The luteinization and cumulus expansion processes will be further detailed 
in the Chapters 2 and 3 of this thesis, respectively. 
  2 
The physiological response induced by the reproductive endocrine and molecular 
events determines the phases of the female estrous cycle. The estrous cycle is comprised of 
proestrus, estrus, metestrus and diestrus phases. Monitoring the estrous cycle is a relevant 
tool for the studies in reproductive biology in the mouse, which is an important animal 
model in research. In the appendix section (Chapter 5) of this thesis, the mouse estrous 
cycle is described, including the reproductive tract changes and the methods of 
identification of the estrous phases. 
Mutant mouse models have been widely used in research, and from knowledge 
obtained by the targeted disruption of genes it has become possible to identify the orphan 
nuclear receptor Nr5a2 as a key regulator of the ovulatory process. A conditional knockout 
mouse model showed that the depletion of Nr5a2 in granulosa cells of primary follicles 
results in female infertility in mice25. Because Nr5a2 is expressed in the ovary of various 
species, it is a potential target as the cause of and the solution to the problem of female 
fertility both in animals and in humans.  
The information about the nuclear receptor Nr5a2 is reviewed based on a substantial 
ensemble of published scientific articles, acquired fewer than two decades of work since its 
first identification, from research in different fields. Nr5a2 is expressed in a wide variety of 
tissues and performs essential roles in maintaining the organism. The purpose of this 
investigation was to determine the role of Nr5a2 in female fertility, with focus on when 
Nr5a2 is essential for and how it regulates luteinization and cumulus expansion in the 
mouse ovary, and whether its expression is required for oocyte fertilizability. 
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1. Literature review 
The nuclear hormone receptors are a superfamily of intracellular transcription 
factors that regulates gene expression, directing proliferation, differentiation and 
apoptosis43. The first indications of their presence occurred in the mid-1900s, with the 
isolation of the estrogen receptor8, and thereafter a number of different steroid hormone had 
been isolated and characterized, including progesterone and testosterone, with the 
subsequent cloning of their respective receptors55. In mammals, the nuclear receptor 
superfamily is composed of approximately 50 functional members, with 48 genes identified 
in the human genome, 49 in mice and 47 in rats138. This review is focused on one of these, 
the nuclear receptor Nr5a2, comprising the gene description, the regulation of its activity 
and the various biological functions, with emphasis on the events related to reproductive 
biology.  
1.1. Nr5a2  
Nr5a2 is a member of the large nuclear receptor superfamily of intracellular 
transcription factors. The history of the Nr5a2 nomenclature, as well as the influence of the 
related nuclear receptor Nr5a1 in instigating the studies about Nr5a2, will be herein 
characterized.  
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1.1.1. Nomenclature: on the way to consensus  
What do the fushi tarazu factor 1 (Ftz-F1), the liver receptor homolog-1 (Lrh-1), the 
human B1-binding factor (hB1F), the Cyp7a promoter-binding factor and the α-fetoprotein 
transcription factor-1 (FTF) have in common? They are some of a long list of names given 
to ortholog and homolog genes of the officially named nuclear receptor subfamily 5, group 
A, member 2 (Nr5a2)82. The reason for the discrepancy in the Nr5a2 nomenclature can be 
assigned to at least three factors, all related to its research history.  
1.1.1.1. From Drosophila to human 
Motivated by the goal of studying the mechanisms of gene regulation, several 
groups independently described the same transcription factor, Nr5a2, as indicated by 
homology studies, but named it according to its functions in various domains of research. It 
was in the early 90’s when the initial evidence of a gene responsible for the transcriptional 
activation necessary for the proper expression of the fushi tarazu (Ftz) was described in the 
Drosophila (D. melanogaster). The Ftz is a member of the pair-rule class of genes 
governing Drosophila embryo segmentation, and the purified sequence-specific 
deoxyribonucleic acid (DNA)-binding factor was then called Ftz-F1, containing a pattern of 
expression coincident to that of the Ftz116. Ftz-F1 is a regulator of embryogenesis and 
metamorphosis in this organism and it was the first Nr5a member cloned100.  
One year later, research in the mouse characterized the liver receptor homologous 
protein115, the primary reference to Lrh-1. By a sequence comparison of the Ftz-F1 and the 
finding of an identical corresponding region of the mouse Lrh-1 (the so-called Ftz-F1 box) 
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it was suggested that these two genes constitute a unique subfamily of nuclear receptors117. 
Based on the sequence similarities and amino acid analysis indicating a common modular 
structure with the nuclear receptors, the human homolog of the Ftz-F1 was named as hB1F, 
for human B1-binding factor, first described in the human liver68. Moreover, another name, 
Cyp7a promoter-binding factor, is related to the known function of the gene in the liver83, 
and the FTF is justified by the role of Nr5a2 in regulating the transcription of α-fetoprotein, 
which binds to estrogens and protects the embryos36. Thus, diversified and parallel research 
on Nr5a2 resulted in a plethora of independent synonymous. 
 1.1.1.2. From receptor to ligand 
Another reason why Nr5a2 has different names is due to the fact that it is an orphan 
nuclear receptor. The nuclear receptor superfamily represents a group of gene-specific 
transcription factors and it is typically subdivided into seven subfamilies (N0 – N6), with 
three classes based on the important diversity among them30. Historically, endocrinology 
studies provided new insights by discovering new hormones through analysis of their 
effects on physiological or developmental processes, and the purified hormone was 
subsequently used to identify its partner receptor55. This is how the steroid receptor family 
(class I) was discovered, including the progesterone receptor, estrogen receptor, 
glucocorticoid receptor, androgen receptor and mineralocorticoid receptor; and also the 
thyroid/retinoid family (class II), including the thyroid receptor, vitamin D receptor, 
retinoic acid receptor and peroxisome proliferator-activated receptor (PPAR)4.  
Nonetheless, the concept of the orphan nuclear receptors introduced a new era in  
endocrinology, in which the process of ligand-receptor discovery is inverted. The orphan 
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receptors were cloned and than they are used to search for previously unknown ligands, 
what could be called “reverse endocrinology”55. The orphan nuclear receptors compose the 
third family of nuclear receptors (class III), defining a set of proteins identified as 
belonging to the nuclear receptor superfamily by comparative sequence analysis, but for 
which the cognate ligand has not yet been identified and the molecular mechanisms of their 
transcriptional regulation remain unclear4. The orphanhood of Nr5a2 explains why research 
groups named it according to its transcriptional functions at the moment of its discovery, 
and does not represent the absolute gene function.  
1.1.1.3. From diversity to consensus 
After almost 10 years of research on Nr5a2, the scientific community agreed to 
unify the nomenclature system for the nuclear receptor superfamily. A committee created in 
1999 decided the current official nomenclature of nuclear receptors, justified by the 
frequent existence of multiple names for the same gene. The system is convenient and 
flexible, allowing for the inclusion of an ever-increasing number of genes and reducing the 
barrier to researchers outside as well as within the field for understanding both classic and 
newly acquired information23. According to the nomenclature system, each gene name 
starts with “NR” for nuclear receptor, followed by the Arabic number corresponding to the 
subfamily, then a single letter for the group and then an Arabic number again for each 
individual member77. The scheme is depicted in the phylogenetic tree of nuclear receptor 
classification in Figure 1.1.  
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Figure 1.1 : Schematic representation of nuclear receptors classification from NR0 (pink) to NR6 
(yellow). Subfamilies are represented in different colors and the unofficial name for each gene accompanies 
the NR nomenclature. The NR5 subfamily is colored in teal, including the two members Nr5a2 and Nr5a1. 
Adapted from Mooijaart et al., 200577.  
 
1.1.2. The SF-1 legacy 
The advances in the characterization of the Nr5a2 subfamily were undoubtedly 
guided by the abundance of findings on the structure and function of the steroidogenic 
factor-1 (SF-1). According to the unifying nomenclature system for nuclear receptors, SF-1 
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is the member 1 of the Nr5a subfamily (Nr5a1), and it is the closest mammalian homolog1 
to the Nr5a230. Nr5a1 was first defined as a mammalian ortholog2 of the Drosophila Ftz-
F160, belonging to the nuclear receptor family, on the basis of their sequence identity89.  
As early as 1997, the literature relative to Nr5a1 was reviewed by the late Keith 
Parker, who defined it as a key determinant of the endocrine function within the 
hypothalamic-pituitary-gonadal axis at various levels, with transcripts detected in 
steroidogenic tissues known to express the cytochrome P450 steroid hydroxylases, 
regulating genes involved in steroid hormone biosynthesis, hence its name. In vivo data for 
Nr5a1 were becoming available at that time, showing its essential role in sex 
differentiation, by activating the expression of the anti-Müllerian hormone (Amh), and 
adrenal and gonadal formation71; 89.  
Nr5a1 is expressed in the hypothalamus, pituitary, adrenocortical cells, testicular 
Leydig cells and ovarian theca cells, with lower levels present in granulosa cells and no 
expression in luteal cells30. Data from targeted mutagenic disruption in the ovary showed 
aberrations in follicle development, anovulation, compromised granulosa cell proliferation 
and decreased expression of steroidogenic genes8.  
Numerous studies have demonstrated that both Nr5a1 and Nr5a2 are essential for 
the success of diverse regulatory processes in mammals, and that both are crucial for 
normal embryonic development8. They have a high degree of similarity in the amino acid 
sequence of their DNA binding domain (DBD, 95%), thus, both transcription factors can 
bind the same DNA sequences. Despite their structural conservation, they achieve a 
remarkable specificity both in the way they are activated and in the way they selectively 
                                                
1 Homolog : a gene related to a second gene by descent from a common ancestral DNA sequence. 
2 Ortholog : genes in different species that evolved from a common ancestral gene by speciation. 
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induce specific target genes and signaling pathways30. Nr5a1 and Nr5a2 clearly derive from 
separate genes and have a different pattern of distribution in the mammalian tissues89; they 
also have distinct structural ligand binding domains (LBD, 76%), and regions that recruit 
specific cofactors to regulate transcription. The integration of the variant domains within 
the receptor results in the specificity of their activities, contributing to their different 
biological functions98. 
Nr5a2 is mainly expressed in tissues of endodermal origin, including the liver, 
pancreas and intestine; high levels of Nr5a2 are also found in the ovary30 and, at lower 
levels, in the endometrium135 and the placenta, as well as in the adrenal and the testis107. In 
general, most Nr5a2 data were generated based on the discoveries about the Nr5a1; 
therefore Nr5a1 was the pioneer instigator of the Nr5a2 brainstorm that generated a 
growing mass of data contributed by studies from the highly varied areas of research.  
1.2. Nr5a2 and its molecular structure 
1.2.1. Nuclear receptor interactions with target sequences 
Among the three classes of nuclear receptors (previously described in the section 
1.1.1.3), there are subtle differences in the biochemical mechanisms by which the receptors 
carry out their functions. The member of the class I steroid receptor family, upon binding 
their hormonal ligand, translocate into the nucleus and bind as homodimers to the response 
elements5. The class II receptor proteins typically function as heterodimers. The orphan 
nuclear receptor Nr5a2, belonging to the class III of nuclear receptors, is known to bind as a 
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monomer to the target DNA117 via the C-terminus of its DBD30. Figure 1.2 depicts the 
variation in binding systems used by the nuclear receptors.  
  
 
Figure 1.2 : Scheme illustrating the different dimerization of nuclear receptors. Many members of 
the nuclear receptor family form homo- or heterodimers86. As with SF-1 (Nr5a1), Nr5a2 binds to the target 
DNA as a monomer. 
 
1.2.2. Nr5a2 and its modular domains 
Nr5a2 was classed with the nuclear receptors because it has the typical structure of 
this family, albeit, with some peculiarities. As a nuclear receptor, it must be imported from 
the cytoplasm into the nucleus via the nuclear pore complex (NPC), and it has two 
functional nuclear localization signals (NLSs), responsible for mediating the location of 
Nr5a2 into the nucleus129. Nr5a2 structure is basically composed of (Figure 1.3):  
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• a modulatory N-terminal A/B domain; however, in contrast to other nuclear 
receptors, no ligand-independent activation function-1 domain (AF-1) has been identified30;  
• the highly conserved DBD (or C domain), responsible for targeting the receptor 
to specific DNA sequences, termed hormone response elements; 
• the LBD (or E domain), which contains a conserved ligand-dependent activation 
function-2 (AF-2) motif that mediates co-activator interaction;  
• and the D domain serving as hinge between DBD and LBD89; 30; 129, recently 
showed to be more than a flexible connector, as it is required to regulate the transcriptional 
activity of Nr5a2 in humans128 and important for effective in vitro phosphorylation of 
Nr5a264.  
Members of the Nr5a subfamily contain a hallmark feature, which is an additional 
30-amino acid carboxyl-terminal extension, designated Ftz-F1 box or A box89, located 
adjacent to the second zinc finger motif, at the C terminus of the DBD. The Ftz-F1 box, 
together with the zinc finger region, are responsible for the high affinity binding of Nr5a2 
to its target gene117, dictating the specificity of Nr5a2 regulatory mechanism61.  
The human gene encoding Nr5a2 spans over 150 kb of the chromosome 1, it has 
eight exons and seven introns, and exons 3, 4 and 5 appear to be very important. 
Transcription from two polyadenylation signals results in 3.8 and 5.2 kb transcripts136; 61, 
giving rise to two bands on a Northern blot. At least three Nr5a2 isoforms derived from 
alternative splicing are known to exist in humans30. Figure 1.3 represents the genomic and 
protein structure of human Nr5a2. 
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Figure 1.3 : Structure of the gene, mRNAs and protein isoforms of Nr5a2 (human liver receptor 
homolog-1 – hLRH-1). The human Nr5a2 genomic sequence consists of eight exons. The hLRH-1 isoform is 
identical to hLRH-1v1 except for a deletion in the A/B domain, due to splicing of exon 2. The hLRH-1v2 
isoform contains a deletion within the D or E domain, resulting from an alternative splicing event in exon 5, 
in addition to the splicing of exon 2. As shown, specific exons encode particular hLRH-1 protein domains. 
Protein structure contains the amino acid alignment, evidencing the Ftz-F1 box between the C and D 
domains30.  
 
1.2.3. LBD in charge for the constitutive activity 
Nuclear receptors have amino acid sequence similarity for the two highly conserved 
domains – the DBD and the LBD, and the last is responsible for binding small lipophilic 
ligands108, serving as a molecular switch that recruits coregulatory proteins and activates 
the transcription of target genes when flipped into the active conformation by hormone 
binding55. Many of the nuclear receptors act as ligand-inducible transcription factors43 and 
their activity is controlled by the binding of ligands, including hormones and metabolites30. 
Nr5a2 is constitutively expressed in the nucleus, and its crystal structure shows a large and 
empty hydrophobic ligand-binding pocket, suggesting that its activation is probably 
independent of ligands98.  
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Nr5a2 has structural differences involving the Nr5a-specific N-terminal region of 
the LBD, which is likely to be the explanation for its capacity in constitutive activating 
target genes61. The LBD of most nuclear receptors consists of twelve α-helical regions, 
folded into a three-layered anti-parallel helical sandwich61. An extended rigid structure of 
helix 2 (H2) forms a structure with four layers in the helical sandwich, rather than three 
layers as in the other classical nuclear receptors LBDs98. Through the extension of H2, the 
active position of H12 is stabilized. H12 contains the C-terminal activation helix AF-230, 
and the folding over the AF-2 region allows the LBD to be held in an active conformation, 
tightly related to the ligand-independent property of Nr5a261.  
1.3. Nr5a2 and regulation of its activity 
In this section, the transactivational activity of Nr5a2 will be described, including 
the binding of phospholipid ligands, post-translational mechanisms and the action of 
transcriptional co-activators and co-repressors. Recently, it was discovered that synthetic 
ligands can regulate Nr5a2 activity.  
1.3.1. Phospholipids 
As described in the previous sections, a stable active monomeric Nr5a2 LBD can 
exist in the absence of ligand, coactivator peptide or homo- or heterodimeric receptor 
partner. Although ligands are dispensable for Nr5a2 basal activity, adding bulky side chains 
into its empty hydrophobic ligand-binding pocket results in full or greater activity, 
suggesting that Nr5a2 can accommodate potential ligands98. Through the crystallization of 
Nr5a2 LBD, independent groups have shown that small phospholipid ligands, such as 
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phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, and 
phosphatidylinositol-phosphates34 can interact with Nr5a2 LBD, with consequent effect of 
regulating gene expression56; 87. 
Further, by molecular dynamic simulations, it was demonstrated that phospholipids 
cause no overall structural changes in the Nr5a2 conformation, rather ligand binding affects 
the interactions with cofactor peptides14. It is suggested that the phospholipid molecule is 
not an endogenous ligand for Nr5a2, and even that there might be no endogenous ligand for 
this receptor137. Therefore, it remains to be determined whether phospholipids or possibly 
other molecules can regulate Nr5a2 under physiological conditions in vivo.  
1.3.2. Post-translational regulation 
Nr5a2 possesses a large hinge domain that is subject to post-translational 
modifications56. Specifically, phosphorylation of the Nr5a2 regulatory hinge region, 
brought on by activation of the protein kinase-C pathway and the MAPK/ERK pathway, 
increases its transcriptional activity64. A second post-transcriptional modification is the 
conjugation of Nr5a2 to the small ubiquitin-like modifier (SUMO), at lysine residues 
(sumoylation)130. Post-translational modification by SUMO elicits a repressive effect on 
many transcription factors. Nr5a2 was demonstrated to be a direct substrate for the SUMO 
conjugation machinery and sumoylation can modulate its activity18. The inhibition of 
Nr5a2 transcriptional activity by sumoylation takes place by reduction in the binding of the 
receptors to their cognate DNA sequence16, or by transport of Nr5a2 into transcriptionally 
inactive nuclear bodies18; 130. The second messenger, cyclic adenosine monophosphate 
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(cAMP), is believed to be an important signal for regulating the dynamics of the 
sumoylation pathway and Nr5a2 activity130.  
1.3.3. Co-regulators 
In addition to the post-translational mechanisms controlling transactivational 
activity, Nr5a2 is also regulated by the interaction with positive and negative co-regulatory 
proteins, referred to as co-activators and co-repressors85, and this may well be the most 
important mode of functional regulation of orphan nuclear receptors61. In general, in the 
absence of ligand or in the presence of ligand antagonists, the nuclear receptor typically 
interacts with co-repressors. Ligand binding and/or phosphorylation modulate receptor 
function by altering the receptor’s affinity for co-regulatory proteins94, inducing a 
conformational change that results in the dissociation of co-repressor complexes and 
recruitment of co-activator proteins by the nuclear receptors30, and subsequent 
transcriptional activation. Once Nr5a2 is constitutively active, it can interact with co-
repressors to modulate its activity30.  
Co-regulators can modify the chromatin structure, leading either to condensation 
that represses transcription, or to decondensation that facilitates the recruitment of the basal 
transcription machinery of nuclear receptors12. Ligand-activated nuclear receptors serve 
first as adaptors between gene regulatory regions and the chromatin modifying enzyme 
complexes and then as activators of ribonucleic acid (RNA) polymerase II17, to suppress or 
enhance target gene expression. In general, the structure that mediates the ligand-driven 
exchange of co-repressors and co-activators is the helix 12 (H12), which assumes an 
extended position in the absence of ligand, permitting the binding of co-repressors. Binding 
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of agonist reorients H12 to a sequestered position that blocks the co-repressor binding site 
while simultaneously forming a new docking surface for co-activators94. As previously 
discussed, the long H2 twists Nr5a2 into an agonist-like conformation by affecting H12, 
even when Nr5a2 ligand binding pocket is empty98.  
Nr5a2 effects are modulated by the repressive actions of the Nr0 family of orphan 
receptors, comprising the short heterodimeric partner (SHP, Nr0b2) and dosage-sensitive 
sex reversal adrenal hypoplasia congenital region on the X chromosome, gene 1 (DAX1, 
Nr0b1). SHP and DAX1 inhibit the interaction of Nr5a2 with co-activators, thereby 
reducing its constitutive transcriptional effects8. These two receptors are unique among the 
nuclear receptor family in that they lack their own DBD38, and DAX1 has neither the 
modulatory domain nor the hinge region49.  
Physiological feedback loops have the capacity to regulate Nr5a2 by the induction 
of SHP expression, which represses Nr5a2 activity by interacting with its AF-2 
transactivation domain. AF-2 is a common target for co-activator interaction, so SHP not 
only directs transcriptional repression, but also competes with co-activators for binding to 
Nr5a265. In contrast to other nuclear receptors, ligand binding does not effect 
conformational change; rather it reduces the affinity of Nr5a2 for SHP14. By this means, 
ligand binding may increase transcription by reducing inhibition. On the other hand, Nr5a2 
undergoes conformational changes to accommodate the SHP docking in a potent and 
selective way69.  
Nr5a2 interacts through its LBD with the N-terminal LXXLL related motifs in 
DAX1112, binding with high affinity to the AF-2 domain. DAX1 functions as a ligand-
independent nuclear receptor and its repressive mechanism indicates that it is a competitive 
transcriptional co-repressor99. There is also evidence that DAX1 recruits co-repressors, 
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such as the nuclear receptor co-repressor (NCOR) and ALIEN, providing a further 
mechanism of inhibition of Nr5 nuclear receptor activity49.  
In addition to the DAX1 and SHP, other co-activators and co-repressors participate 
in regulating Nr5a2 transactivation of target genes. The repressor interacting protein 140 
(RIP140) is a negative transcriptional regulator of nuclear receptor action32. The prospero-
related homeobox transcription factor, Prox1, is another recognized co-repressor that 
directly interacts with both LBD and DBD of Nr5a295; 109. Indirect mechanisms have also 
been shown to inhibit the activity of Nr5a2, such as the case of the silencing mediator for 
retinoic acid and thyroid hormone receptor (SMRT) that regulates but does not directly 
interact with Nr5a2126.  
Nonetheless, inhibition is not the sole regulatory mechanism of Nr5a2 
transactivation. The multiprotein bridging factor (MBF-1) is a co-factor that enhances the 
transcriptional activity by interacting with the Nr5a2 Ftz-F1 box, acting as a bridging factor 
enabling interactions of Nr5a2 with the transcription machinery, although it does not 
possess histone-modifying activities, which are typical for many co-activators12. Steroid 
receptor co-activator-1 (SRC-1) interacts directly with the Nr5a2 LBD in helix 1 and AF-2, 
significantly potentiating its transcriptional activity127. The protein inhibitor of activated 
STAT (signal transducer and activator of transcription) y (PIASy) interacts with Nr5a2 in 
the AF-2 motif as well, inhibiting the binding of SRC-1 to Nr5a2, markedly repressing 
Nr5a2 transactivation in a competitive way48.  
The co-activator PPAR-γ-coactivator-1 (PGC-1) interacts with and enhances Nr5a2 
transcriptional activity102. PGC-1 binds to the AF-2 domain of Nr5a2, and it has been 
suggested to be a key factor that promotes differentiation of granulosa cells into 
progesterone-producing luteal cells by regulating Nr5a2132. Recently, a novel isoform and 
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promoter region of Nr5a2 in human granulosa cells was shown to be coordinately regulated 
by Nr5a1 and PGC-152. Blocking PGC-1 is one of the strategies used by SHP and DAX1 to 
repress Nr5a2 activity61. Nr5a2 inhibition is also possible by means of preventing the 
recruitment of PGC-1 by the sterol regulatory element-binding proteins (SREBP-2)51. In 
addition to this wide and growing list of co-regulators for Nr5a2, it has been shown that β-
catenin is important for stable interactions with Nr5a2. The Nr5a2 surface that engages β-
catenin is distinct from the known interaction surfaces of Nr5a210; 133. The regulation of 
Nr5a2 by co-regulatory proteins is a complex and fertile field of research, as partially 
represented in Figure 1.4.  
 
Figure 1.4 : Schematic representation of the role of co-activators and co-repressors in modulating the 
constitutive transcriptional activity of Nr5a2 (Lrh-1). A number of transcription factors, including those of the 
GATA family and CREB act in synergy with Nr5a2 to induce transcription of target genes. Co-activators such 
as SRC-1and PGC-1 interact directly with Nr5a2 to upregulate transcription. The orphan nuclear receptors of 
the NR0 family, DAX1 and SHP repress transcription by competitively inhibiting the interaction of Nr5a2 
with co-activators8. 
1.3.4. Synthetic ligands 
The identification of synthetic ligands for Nr5a2 provides proof of concept for 
ligand-dependent activation or inhibition. An early synthetic small molecule agonist for 
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Nr5a2 was the compound GSK8470, identified as a high-affinity ligand for Nr5a2 in liver 
cells123. Another small molecule known to activate Nr5a2 is the herbicide atrazine, but the 
precise mechanism leading to the increased receptor activity has not yet been defined124. A 
breakthrough into the activation of the Nr5a2 domain was the discovery of dilauroyl 
phosphatidyl-choline (DLPC) as an agonist ligand, by regulating Nr5a2 functions of bile 
acid metabolism and glucose homeostasis in vitro, and the administration of this lipid to 
diabetic mice reduces blood glucose levels63. This molecule ushered in the use of chemical 
tools to investigate the biological function of Nr5a2 in vitro and points to the further 
therapeutic utility of this nuclear receptor.  
Musille et al. report that DLPC binding to Nr5a2 is a dynamic process that alters co-
regulator selectivity, by simultaneously enhancing co-activator peptide recruitment and 
disfavoring co-repressor peptide interaction. DLPC is able to competitively displace larger 
phospholipids from the LBD of Nr5a2 in vitro. Nr5a2 undergoes profound structural 
changes upon DLPC binding, and functional studies have confirmed the viability of Nr5a2 
as a therapeutic target for both agonist and antagonist design81. Both humans and mice were 
shown to respond to DLPC, however the Drosophila ortholog is incapable of DLPC 
binding. The use of mice as viable therapeutic models for Nr5a2-dependent diseases is a 
valid concept80.  
The inverse agonist is a molecule that binds to the same receptor as an agonist but 
induces a pharmacological response opposite to that agonist. Nr5a2 inverse agonists have 
been synthesized, and two probe compounds, ML179 and ML180, have been tested in 
transcription assays. These have been used in cell biological studies to elucidate the role of 
Nr5a2 in vitro and may also be useful in the development of repressive therapies for Nr5a2-
related disease15. Another possibility of therapeutic method by the use of synthetic ligands 
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is the 4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3Cl-AHPC). 3Cl-
AHPC is not a direct ligand for Nr5a2, but it binds to SHP and mediates Nr5a2 repression 
by increasing their interaction76. 
Finally, the two first small molecules-antagonists of Nr5a2 have now been 
described. These ligands inhibit the transcriptional activity of Nr5a2 by affecting the 
transcriptional co-repressor targets SHP, cyclin E1 and G0S2 genes that are known to 
regulate cell growth and proliferation. Nr5a2 antagonists also diminish the expression of 
the receptor’s target genes, and mediate the inhibition of Nr5a2-related cancer cell 
proliferation6. Figure 1.5 illustrates the difference between the action of an agonist, 
antagonist and inverse agonist.  
 
 
Figure 1.5 : Schematic representation comparing the action of an agonist, antagonist and inverse 
agonist101. R* and R means active and inactive state, respectively. An agonist will bind to the receptor and 
trigger a response; an antagonist does not provoke a biological response itself upon binding to a receptor, but 
blocks or dampens agonist-mediated responses; whereas an inverse agonist causes an action opposite to that 
of the agonist (reprinted from Saevarsottir, 2008). 
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1.4. Nr5a2 and its biological functions 
The nuclear receptor Nr5a2 controls a wide array of biological processes, including 
eukaryotic development, reproduction and metabolic homeostasis4. Because of its versatile 
signaling functions and its implication in many physiological processes, Nr5a2 is a 
potential drug target, motivating both basic and applied biomedical researchers30. In this 
section, particular attention will be given to the functions of Nr5a2 in steroidogenesis and 
reproduction, to include its role in pluripotency and in human breast cancer. Table I 
summarizes the functions, the target genes and the localization of Nr5a2 in adult and 
embryonic life. 
 
TABLE I : Nr5a2 target genes and functions (reviewed by Lazarus et al., 201261). 
 
 
1.4.1. Nr5a2 in homeostasis, metabolism and development 
Nr5a2 regulates important steps of development, endocrine homeostasis and 
metabolism. The pattern of expression of Nr5a2 in the liver, pancreas, intestine and also in 
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the adrenal has been described above. The functions of Nr5a2 in these organs will be 
briefly described.  
1.4.1.1. Embryonic development 
Nr5a2 is expressed in the morula and inner cell mass of the early embryo39, and 
mice homozygous for a germline mutation in the gene encoding Nr5a2 die between 
embryonic (E) day E6 and E7.5, which corresponds to the gastrulation period, indicating 
that it plays a crucial role in the development88. Gastrulation is a phase early in the 
embryonic development, during which the single-layered blastula is reorganized into the 
gastrula, which contains three germ layers known as the ectoderm, mesoderm, and 
endoderm. The failed gastrulation is believed to be secondary to defective visceral 
endoderm development. The Nr5a2 homozygous embryos display growth retardation, 
epiblast disorganization, and impaired primitive streak morphogenesis57.  
Mouse embryonic stem (ES) cells express Nr5a2 abundantly; at day E7.5, Nr5a2 is 
detected in foregut endoderm, following the differentiation of the foregut into liver, 
intestine and pancreas, where Nr5a2 is progressively expressed. At day E17.5, Nr5a2 
exhibits its adult expression profile in the liver, exocrine pancreas, intestinal crypts and 
stomach epithelium30. By day E11.5, bipotential gonads express Nr5a2; by day E13.5 testis 
and ovaries become anatomically distinct, and the signal for Nr5a2 declines in the 
developing ovary and testis at day E15.5. This signal is increased again just in the postnatal 
ovary on day 2, in primordial follicles in both oocyte and granulosa cells, providing 
evidence for a potential role for Nr5a2 in gonadal development, in initiation of 
folliculogenesis and regulation of estrogen biosynthesis within the ovary47.  
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1.4.1.1.1. Nr5a2 and pluripotency 
Transcription factors, such as the Oct4, Sox2, Foxd3 and Nanog, are pivotal in 
supporting the maintenance of ES cells, which are pluripotent and known for their ability to 
self-renew and to differentiate into cells of the embryonic germ layers42. Nr5a2 and Oct4 
are co-localized in the inner cell mass and in the embryonic epiblast, and Nr5a2 is required 
to maintain Oct4 expression at the epiblast stage of embryonic development (Figure 1.6), 
thereby maintaining the pluripotence of ES cells39. The Oct4 regulation is mediated by the 
interaction of Nr5a2 and DAX1, which typically acts as a co-repressor, but in this case, it 
differently results in the transcriptional activation of Oct453.  
 
                          
Figure 1.6 : Embryonic development from fertilization to primordial germ cell formation. The 
epiblast is derived from the inner cell mass of the blastocyst, and it differentiates to form the three germ layers 
known as ectoderm, endoderm and mesoderm in a process called gastrulation. Adapted from Zhao and 
Garbers, 2002139.  
 
  
25 
The reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is 
possible by the introduction of factors such as Oct4, Sox2, Klf4 and c-Myc, and, among 
them, Oct4 is critical in inducing pluripotency due its uniqueness in being irreplaceable by 
other transcription factors. However, in 2009, Nr5a2 was shown to be capable of replacing 
Oct4 in the derivation of iPSCs from mouse somatic cells, enhancing reprogramming 
efficiency41.  
The factor leukemia inhibitory factor (LIF) is important to maintain pluripotency in 
culture, but it is dispensable for self-renewal in vivo.  A recently identified pathway for the 
regulation of self renewal in ES cells is the canonical Wnt regulation of Nr5a2, by which β-
catenin promotes pluripotency gene expression in an Nr5a2-dependent manner, resulting in 
the regulation of Tbx3, Nanog and Oct4 pluripotency factors121. Moreover, the epiblast 
stem cells (EpiSCs) are pluripotent cells derived from post-implantation mouse embryos 
from day E5.5 to E7.5, and they differ from ES cells because EpiSCs do not colonize host 
embryos when injected into the blastocyst. Nr5a2 is also an inducer of pluripotency in the 
EpiSCs, but in this case its activity is additional to inducing or replacing Oct440. 
1.4.1.2. Intestine and liver 
Nr5a2 was originally identified in the liver, and it is known for being involved in 
cholesterol and bile acid homeostasis by regulating the expression of a number of rate-
limiting enzymes in the reverse cholesterol transport and bile acid synthesis pathways. 
Further, it has emerged as a key regulator of intestinal function66. The importance of Nr5a2 
in homeostasis is due to its regulation of: 1) reverse cholesterol transport, by regulating the 
cholesteryl-ester-transfer protein (CETP) and scavenger receptor B1 (Scarb1), which are 
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crucial regulators of the transport of high density lipoprotein (HDL) from peripheral tissues 
to be excreted by the liver; 2) bile acid synthesis, which are water-soluble end products 
from cholesterol metabolism and essential for efficient absorption of dietary lipids, in 
which Nr5a2 was first showed to participate by regulating the gene transcription of the rate-
limiting enzyme in bile acid biosynthesis, the cholesterol 7 alpha-hydroxylase (Cyp7a1), 
and the cytochrome P450 family 8 subfamily B polypeptide 1 (Cyp8b1), as showed in 
vitro; and 3) enterohepatic bile acid circulation30.  
However, by the use of targeted somatic mutagenesis in mouse hepatocytes, in vivo 
data showed that Nr5a2 regulates Cyp8b1, but not Cyp7a173, suggesting that Nr5a2 either is 
not important, or plays a minor role for Cyp7a1 expression in vivo, or moreover the 
regulation is compensated for by other factors. Recently it was discovered that the 
hepatocyte nuclear factor 4-alpha (HNF4α) works in concert with Nr5a2 to regulate 
Cyp7a1 transcription, by cooperating to maintain its basal expression54. Nr5a2 is also 
involved in the control of the inflammatory response at the hepatic level, modulating the 
so-called acute-phase response, which is the host reaction in response to trauma, infection, 
tissue damage or acute inflammation118.  
Nr5a2 controls intestinal inflammation in response to immunological stress by 
triggering local glucocorticoid production, which controls the activation of local intestinal 
immune cells78, and it is suggested to initiate intestinal tumorigenesis both by affecting cell 
cycle control as well as through its role on inflammatory pathways105. Surprisingly, when 
Nr5a2 is disrupted in the intestinal epithelium in vivo, no evident macro or microscopic 
abnormalities were observed, nor there were changes in the triglyceride, free fatty acid, 
glucose or bile acid parameters, and plasma cholesterol was modestly decreased66. 
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The cell proliferation is another role for Nr5a2, described first in the intestinal cells. 
It simultaneously induces G1 cyclin D1 and E1 in intestinal crypt cells, potentiated by its 
interaction with β-catenin, promoting cell renewal via the crosstalk with β-catenin/Tcf4 
signaling pathway10. Combining Nr5a2 competence in proliferation and cell renewal with 
the role in inflammation, it is not surprising that an aberrant Nr5a2 expression can be 
associated with tumors, including colon and gastric cancers24. These tumorigenesis 
interactions are schematically represented in Figure 1.7. 
 
 
Figure 1.7 : Nr5a2 drives cell cycle progression and tumorigenesis by synergizing with the β-catenin 
signaling pathway, acting directly as a transcription factor (cyclin E1) and as a cofactor for Tcf-β-catenin 
(cyclin D1) in the gut (from Fernandez-Marcos, 2011)33. 
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1.4.1.3. Pancreas 
In the pancreas, Nr5a2 is co-expressed with the pancreatic-duodenal homeobox 1 
(PDX-1) during embryonic development, and PDX-1 controls Nr5a2 expression in the 
mouse from E8.5 to E16.530. Consequently, Nr5a2 participates in the regulatory cascade 
governing pancreatic development, differentiation and function3. In the adult, Nr5a2 
expression becomes restricted to the murine exocrine pancreas67, where it regulates a 
specific transcriptional network required for the production and secretion of pancreatic 
juice, for instance, the carboxyl ester lipase (CEL), which is important for the enterohepatic 
cholesterol homeostasis31. Recently, an in vivo study has shown that Nr5a2 is not required 
for the specification or development of acinar cells, but it is important for maintaining the 
acinar identity and reestablishing acinar fate during regeneration120. 
In 2010, Nr5a2 has been identified as a significant predisposing factor for pancreatic 
cancer, through a genome-wide association study92, and its expression is found to be 
elevated in human pancreatic ductal adenocarcinomas7. The activation of Nr5a2 
transcription mediates proliferation and differentiation in the pancreatic ductal, via 
regulation of cyclin D1, E1 and c-Myc, and moreover, it regulates cell cycle arrest in 
pancreatic cancer cells61. The possible link between Nr5a2 and pancreatic dysfunctions 
raised the speculations on whether Nr5a2 is related to diabetes. It has been determined that 
Nr5a2 plays an important role in the transcriptional activation of the adiponectin gene, 
which is a potential candidate for the association of obesity, diabetes and increased risk of 
pancreatic cancer67.  
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1.4.1.4. Other tissues 
The expression of Nr5a2 is not restricted to any single system, indeed, it is widely 
expressed throughout the mammalian organism. Nr5a2 has been shown to be expressed in 
murine stomach, tongue, gall bladder, alveolar type II cells of the respiratory system, 
transitional epithelium of the urinary system, brown adipocytes, cardiomyocytes and 
hypothalamus44, but its functions in these tissues have not yet been explored in any depth.  
In the rat anterior pituitary gland and in gonadotropic cell lines, Nr5a2 was shown to 
regulate gonadotropin gene expression, activating the follicle-stimulating hormone (FSH)β 
and luteinizing hormone (LH)β promoter in vitro140. On the other hand, a recent study using 
a mouse model with a gonadotrope specific deletion of Nr5a2 demonstrated that its 
expression in the pituitary is dispensable in vivo, since these mice had normal pituitary 
FSHβ and LHβ expression and intact fertility35.  
Studies in humans have shown that Nr5a2 is expressed in bone cells, modulating 
gene expression in osteoblasts and associated with bone mass96; and in the adrenal gland, 
possibly regulating steroidogenesis122. This last study was among the earliest to stimulate 
investigations on the role of Nr5a2 in gonadal steroid hormone production. Indeed, it is 
now known that Nr5a2 is expressed in the testicular Leydig cells and in ovarian follicular 
cells44, and its function in reproductive related events had become an intringing and 
interesting area of research.  
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1.4.2. Nr5a2 and reproduction 
The high level of ovarian and testicular Nr5a2 expression makes it likely that Nr5a2 
plays an important role in the regulation of gonadal function107, and its role in reproduction 
is strongly related to its steroidogenic competence. Nr5a2 is essential for female fertility25, 
and this section will focus on the reproductive events regulated by Nr5a2, from the first 
discoveries to the state of the art.  
1.4.2.1. Nr5a2 in steroidogenesis 
As described previously in the section 1.1.2, Nr5a1 (or SF-1) is expressed in most 
steroidogenic tissues and regulates expression of several steroid-metabolizing enzymes107, 
but its expression is downregulated in the ovarian corpus luteum (CL)46. The CL is a highly 
steroidogenic structure, resulting from the differentiation of theca and granulosa cells, 
producing progesterone. Considering that Nr5a1 and Nr5a2 are closely related, a potential 
role for Nr5a2 in the regulation of gonadal steroidogenesis was established for essentially 
two reasons: 1) Nr5a2 is expressed in the ovary, and this expression is higher in the CL 
compared with ovarian follicular cells91; and 2) the CL should have an alternative 
steroidogenesis regulator other than Nr5a1. Altogether, these hypotheses were the 
inspiration for the “in vitro era” of assays in human ovarian tissue and cells, in order to 
identify Nr5a2 steroidogenic target genes. 
It is now known that, under the control of FSH59, Nr5a2 plays a critical role in the 
regulation of steroidogenic proteins and enzymes by enhancing their activity, including the 
steroidogenic acute regulatory protein (Star), the cholesterol side-chain cleavage enzyme 
(Cyp11a1), the cytochrome P450 17a1 (Cyp17a1), the 3 beta-hydroxysteroid 
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dehydrogenase (Hsd3β) and the steroid 11β-hydroxylase (Cyp11b1)107. Nr5a2 also induces 
the promoter activity of the human and mouse Scarb1, which is involved in steroidogenesis 
by facilitating cholesterol transport104. Moreover, Nr5a2 serves as a critical factor in the 
transcriptional regulation of the aromatase (Cyp19a1) gene expression, hence, estrogen 
biosynthesis in the ovary75. Figure 1.8 represents steroidogenesis in ovarian follicular cells. 
  
 
Figure 1.8 : Enzymes involved in the ovarian steroidogenesis. The precursor cholesterol is 
transferred within the steroidogenic cells by the Scarb1, and within the mitochondria by the enzyme Star. In 
the theca cells, cholesterol is converted to pregnenolone by Cyp11a1 (1). The Hsd3β (2) converts 
pregnenolone to progesterone, which is transformed into androgens by the Cyp17a1 (3). Androgens are the 
substrate for estradiol production in granulosa cells, which is catalyzed by the Cyp19a1 (4). Adapted from 
Oakley et al., 201184.   
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1.4.2.2. Nr5a2 in human breast  
The hypothesis that Nr5a2 drives the transcription of aromatase in the breast 
adipose tissue came to be because of the lack of Nr5a1 expression in this tissue. Nr5a2 
expression was then identified in the preadipocyte fraction of human adipose tissue, 
including the stromal compartment of human breast, regulating the expression of 
aromatase22 by binding to the alternative promoter II and inducing local estrogen 
production30. Aromatase expression is induced 3 to 4 fold in adipose tissue of breast cancer, 
and it represents the source of estrogen for estrogen-dependent breast tumor growth via 
local conversion of circulating androgen precursors21.  
The expression of Nr5a2 in breast cancer is localized in tumor epithelial cells and 
intra-tumoral stroma, and evidence suggests that its expression is tightly connected with 
estrogen signaling pathway. It interacts with aromatase and with estrogen receptor alpha 
(ERα), as shown in the MCF7 breast cancer cell line2. The Nr5a2 promoter contains an 
estrogen response element, thus it not only regulates but it is also regulated by estrogen in 
breast cancer (Figure 1.9)61. Both the expression of aromatase and Nr5a2 are driven by 
tumor-derived factors such as prostaglandin E2 (PGE2), resulting in increased estrogen 
availability for tumor progression21; 141. 
Functionally, Nr5a2 is associated with invasive breast cancer, promoting estrogen-
dependent cell proliferation, motility and cell invasiveness, by remodeling the actin 
cytoskeleton and cleaving E-cadherin19. One mechanism of action for Nr5a2 was recently 
described to be the regulation of a well characterized ER target gene, known as growth 
regulation by estrogen in breast cancer 1 (GREB1). Nr5a2 thus promotes cell proliferation 
by enhancing ER mediated transcription of target genes in a synergistically manner20. 
  
33 
 
Figure 1.9 : Nr5a2 (Lrh-1) actions in the breast cancer cell. Nr5a2 activates aromatase transcription 
leading to increased estrogen synthesis, promoting tumor growth. The estrogen receptor (ERα) activates 
Nr5a2 expression in malignant epithelial cells, suggesting that the Nr5a2 is tightly linked with the estrogen 
signaling pathway (reviewed by Lazarus et al., 2012)61.  
 
Nr5a2 has been involved in invasive breast carcinomas and ductal carcinomas in 
situ, hence it has potential impact as a therapeutic target61. Aromatase inhibitors are 
clinically used in breast cancer treatments, but the decreased estradiol production in a 
global manner gives rise to side effects such as bone loss. For this reason, inhibitors or 
inverse agonists of Nr5a2 represent a strategy of a selective aromatase modulator for the 
development of breast cancer specific therapy15. 
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1.4.2.3. Nr5a2 in the testis  
Given the importance of Nr5a2 to induction of steroidogenic enzymes and factors30, 
it is not surprising that it is highly expressed in the steroidogenic Leydig cells of the testis, 
as well as in pachytene spermatocytes and round spermatids. It plays an important role in 
the regulation of aromatase expression in Leydig cells93, where these factors are co-
expressed106. Nr5a2 appears not to be present in Sertoli cells, which regulate germ cell 
development and where Nr5a1 predominates. Mice heterozygous for Nr5a2 mutation, i.e. 
where only a single functional allele is present, have circulating testosterone levels that are 
less than half their wild type (WT) littermates119. Precocious expression of Nr5a2 in mice 
leads to precocious induction of androgen synthesis and early puberty25.   
In 2006, it was shown that Nr5a2 is involved in the differentiation of mesenchymal 
stem cells (MSCs) into steroid hormone-producing cells, such as testicular Leydig cells, 
inducing the expression of Cyp17a1. Therefore, Nr5a2 could represent a key regulator 
controlling the differentiation of stem cells into steroidogenic lineage, and play a pivotal 
role in steroid hormone production in human Leydig cells131. 
1.4.2.4. Nr5a2 in the ovary  
As previously mentioned, Nr5a2 is highly expressed in the mouse ovary, 
specifically in the steroidogenic granulosa and luteal cells, and distinctly absent in theca 
cells and ovarian stroma46. It has also been identified in equine9, rat27, rabbit1, bovine29; 113 
and human107 ovaries. During folliculogenesis (Figure 1.10), Nr5a2 is expressed in primary 
follicles and at all later stages of follicular development, induced significantly in the CL 
during pregnancy47. Nr5a2 expression precedes aromatase expression during 
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folliculogenesis, serving as a multifunctional steroidogenic factor in ovarian physiology, 
regulating estradiol and progesterone production70, although contrasting data showed no 
effect of Nr5a2 on the induction of estradiol in vitro during granulosa cell differentiation103. 
The expression of Nr5a2 is increased by FSH in granulosa cells, and by prolactin in luteal 
cells27.  
 
 
Figure 1.10 : Follicular development. A number of primordial follicles appear 1 to 2 days after birth, 
when flat squamous pre-granulosa cells surround oocytes. Primary follicles have one layer of granulosa cells 
around the oocyte, acquiring new layers during follicular development; tertiary follicles will develop to antral 
follicles, when granulosa cells differentiate into mural and cumulus cells. When the LH peak occurs, 
immediate changes happen in the follicle including cumulus expansion, ovulation and the CL formation. 
Adapted from Matzuk et al., 200874. 
 
The ovulation process begins when FSH stimulates granulosa cells proliferation and 
LH receptor expression143. The LH surge triggers the reactivation of the oocyte from 
meiosis and the breakdown of the follicle wall. The peak of LH also leads the cumulus cells 
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to produce a hyaluronic acid matrix along which they migrate outwardly from the oocyte26. 
Ovulation is complete when the cumulus-oocyte complex (COC) is released into the 
oviduct142. Successful ovulation and fertilization are correlated with the quantity and the 
quality of the expanded cumulus mass26. Changes in gene expression and follicular 
structure occur with overlapping control and interdependent consequences in the theca, 
granulosa, cumulus and oocyte compartments of the ovarian follicle. Following ovulation, 
granulosa cells remaining in the postovulatory follicle undergo luteinization144. 
In 2007, the essential role of Nr5a2 in reproductive function and steroidogenesis in 
vivo was evidenced for the first time. This study employed mice heterozygous for a null 
mutation of Nr5a2, and the females presented a decreased fertility due to an altered luteal 
function58.  
A breakthrough in the role of Nr5a2 in female fertility was achieved in 2008, by the 
use of a conditional knockout of Nr5a2 gene using a mouse line Cre-recombinase specific 
to granulosa cells of primary follicles, crossed with a mouse line with loxP sites flanking 
the third and fourth exons of the Nr5a2 gene. The Nr5a2 granulosa-specific knockout 
females were infertile, and the principal cause for the sterility was the total failure in 
cumulus expansion and ovulation, which could not be redressed by gonadotropin 
stimulation25.  
The normal expression of a number of genes was disrupted in this mouse model, 
including the steroidogenic genes Cyp11a1, Cyp19a1 and Star; the rate-limiting gene in 
prostaglandin synthesis, the prostaglandin-endoperoxide synthase 2 (Ptgs2); and genes 
associated with cholesterol transfer such as Scarb125. Later, another transgenic mouse 
model was used to study the effect of transient Nr5a2 knockdown in vivo. The females 
presented a consistent reproductive phenotype if compared with the Nr5a2 granulosa-
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specific knockout, but the infertility was fully reversible after the cessation of Nr5a2 
knockdown, with no signs of irreversible changes due to the transient reduction of Nr5a2 
expression37.  
Nr5a2 is also expressed in the mouse and human endometrium, and a recent study 
showed that it is necessary for the promotion of endometrial decidualization and for 
placenta formation135. This was achieved by the disruption of its expression in the ovary 
during luteinization, which resulted in luteal insufficiency, gestational failure, fetal growth 
retardation and fetal death135. Altogether, these data show that Nr5a2 is essential for female 
fertility in both gonads and the uterus (Figure 1.11), and it is considered a potential 
pharmaceutical target for contraception by its role in ovulation.  
 
 
Figure 1.11 : Nr5a2 and the female reproductive system. Nr5a2 is expressed in ovarian luteal cells 
and it is essential for progesterone synthesis during pregnancy. In uterine cells, Nr5a2 is essential in 
implantation, decidualization and placentation (reviewed by Brosens et al., 2013)13.  
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Hypothesis and objectives 
Based on the previous published work on the expression of Nr5a2 in granulosa cells 
of primary ovarian follicles and its essential role in the ovulatory process, we hypothesize 
that Nr5a2 modulates the events leading to ovulation and their consequent luteinization in a 
temporal sequence.  
The purpose of this investigation was to determine the role of Nr5a2 in female 
fertility. 
Specific objectives:  
1. To examine the role of Nr5a2 in ovulation and luteinization at differing 
stages of the follicle maturation by timed tissue specific disruption of Nr5a2 in mouse 
ovarian granulosa cells of primary and antral follicles. The results corresponding to this 
objective are described in the Chapter 2.  
 
2. To determine when Nr5a2 is essential for and how it regulates cumulus 
expansion in the mouse ovary, and whether its expression is required for the developmental 
competence of oocytes to be fertilized. The data related to this objective are described in 
the Chapter 3.  
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2.1. Abstract 
The corpus luteum is a temporary endocrine ovarian structure that produces 
progesterone. Luteal and granulosa cells express the nuclear receptor Nr5a2. Previous 
studies demonstrated that Nr5a2 is required for ovulation and luteal steroid synthesis. Our 
objectives were to analyze the temporal sequence in the regulatory effects of Nr5a2 in the 
ovary, with focus on luteal function. We developed a female mouse model of granulosa-
specific targeted disruption from the formation of the antral follicles forward (genotype 
Nr5a2Cyp19-/-). Mice lacking Nr5a2 in granulosa cells of antral follicles are infertile. 
Although cumulus cells undergo expansion after gonadotropin stimulation, ovulation is 
disrupted in those mice, at least in part, due to the downregulation of the progesterone 
receptor (Pgr) gene. The excision of Nr5a2 in antral follicles permits formation of luteal-
like structures, but not functional corpora lutea as they produced reduced progesterone 
levels and failed to support pseudopregnancy. Progesterone synthesis is affected by 
depletion of Nr5a2 due to, among others, defects in the transport of cholesterol, evidenced 
by downregulation of Scarb1, Ldlr and Star. Comparison of this mouse line with that in 
which Nr5a2 is depleted from the primary follicle forward (genotype Nr5a2Amhr2-/-) 
demonstrates that Nr5a2 differentially regulates female fertility across the trajectory of 
follicular development. 
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2.2. Introduction 
Just prior to birth, the mouse ovary contains a cluster of densely packed oocytes, 
soon to be transformed by the process of follicle assembly28. The product is the primordial 
follicle, formed in the first two days after birth, when flat squamous pre-granulosa cells 
surround the oocytes. Cohorts of these follicles enter the growing pool, and the presence of 
cuboidal and dividing granulosa cells defines these as primary follicles29. The growth of the 
oocyte in this class of follicles correlates with the beginning of anti-Müllerian hormone 
(Amh) expression26. Amh expression is restricted to granulosa cells, first detected in the 
mouse ovary at day 6 after birth and it is known to regulate the number of growing follicles 
and their selection for ovulation26; 12. The expression pattern of the gene encoding the Amh 
type II receptor (Amhr2) overlaps with Amh in postnatal granulosa cells20. 
Primary follicles undergo the transition to secondary follicles, characterized by an 
additional theca layer surrounding more than one layer of granulosa cells. The first antral 
follicles are seen by day 13, and by day 21 after birth, follicles with multiple layers of 
granulosa cells containing scattered areas of interstitial fluid are present. Granulosa cells of 
antral follicles express aromatase, the enzyme responsible for catalyzing the conversion of 
androgens into estrogens. It is encoded by the cytochrome P450 family 19 subfamily A 
polypeptide 1 (Cyp19a1) gene35. This process is essential, as the mouse model lacking 
functional aromatase activity (aromatase knockout – ArKO) is infertile due to disrupted 
folliculogenesis and failure to ovulate6.    
 During the antral stage, follicular granulosa cells differentiate into at least two 
populations, those in layers that surround the oocyte, known collectively as the cumulus 
cells, and the layers that line the follicular wall, known as mural granulosa cells. Cumulus 
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cells are closely connected and form a functional reciprocal communication with the 
oocyte14. The preovulatory LH surge triggers a series of events, including cumulus 
expansion from the oocyte in an extracellular matrix15, a critical process for ovulation13. 
Follicular prostaglandins are mandatorily increased prior to ovulation, induced by selective 
induction of the prostaglandin-endoperoxide synthase-2 (Ptgs2) expression in granulosa 
cells34. Likewise, following the LH peak, mural granulosa cells of preovulatory follicles are 
induced to express the progesterone receptor (Pgr) gene, with the maximum Pgr expression 
at 8 hours after the LH surge, just prior to ovulation2. In the mouse, ovulation ensues at 12 
hours after the LH peak36. The expression of Pgr regulates the proteolytic enzyme, a 
disintegrin and metalloproteinase with thrombospondin motifs-1 (Adamts-1)32, whereas 
Adamts-4, another protease implicated in the ovulatory process, does not appear to be a 
major target of Pgr31.  
  Following ovulation, granulosa and theca cells from the postovulatory follicle 
undergo cellular reorganization to form the corpus luteum (CL), a transient endocrine organ 
that produces progesterone, essential for endometrial cell differentiation and maintenance 
of pregnancy29. The functional remodeling of the follicle to form the CL entails a large 
scale increase in progesterone synthesis, requiring upregulation of cholesterol substrate 
availability27. The scavenger receptor class B type I (Scarb1) is a luteinization marker and 
is the receptor for high-density lipoprotein (HDL), providing much of the substrate 
cholesterol for ovarian steroidogenesis21 during the luteal phase. The rate-limiting step in 
steroidogenesis is the expression of the steroidogenic acute regulatory protein (Star), which 
regulates the cholesterol transfer within the mitochondria. Cholesterol is then converted to 
pregnenolone by the cytochrome P450 side-chain cleavage enzyme (Cyp11a1). Another 
enzyme, 3-hydroxysteroid dehydrogenase (Hsd3β), converts pregnenolone to progesterone 
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that is secreted or can be then transformed into androgens by the 17α-hydroxylase 
(Cyp17a1). Androgens are the substrate for estradiol production by the aromatase activity 
as previously described27.  
 The nuclear receptor Nr5a2, also known as liver receptor homolog-1 (Lrh-1), is 
highly expressed in granulosa cells of primary to preovulatory follicles25 as well as in luteal 
cells19. Germline deletion of Nr5a2 results in early embryo lethality22, thus, there is a need 
for a strategy of conditional depletion to explore its role in the ovary. By means of ovary-
specific depletion, we have previously shown that Nr5a2 is required for multiple events 
essential for ovulation11. It was also reported that Nr5a2 is essential for pregnancy by 
regulating uterine decidualization37. The latter studies further indicated that Nr5a2 is 
required for steroidogenesis in the CL37. To date, these studies have focused either on the 
role of Nr5a2 in ovarian follicular development from primary follicles11 or after the 
luteinizing stimulus37. The consequences of depletion at different times in the 
folliculogenesis suggest that there is a temporal sequence in the regulatory effects of Nr5a2. 
In the present study we explored the role of Nr5a2 using a mouse model with granulosa-
specific knockout in antral and preovulatory follicles. This new model provides insight into 
the role of Nr5a2 in the later stages of follicle development.  
2.3. Materials and methods 
Animals and colony maintenance 
All animal experiments were approved by the University of Montreal Animal Care 
Committee and conducted according to the guidelines of the Canadian Council on Animal 
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Care (CCAC). All mutant and control mice were of the C57BL/6 background. Animals 
were maintained under a 14:10 light:dark cycle and provided food and water ad libitum. 
Euthanasia was performed by anesthetizing the animals with Isoflurane (PPC, Richmond 
Hill, ON, Canada) in a closed container, followed by cervical dislocation. Nr5a2 floxed 
(Nr5a2f/f) mice, generated by Dr. Johan Auwerx, have been described previously5. To 
generate granulosa-specific Nr5a2 mutant in antral follicles, animals expressing Cre-
recombinase from Cyp19a1 (tgCyp19a1Cre/+)17 were crossed with Nr5a2f/f mice  
(Nr5a2Cyp19-/-). To compare two different granulosa-specific mouse models, we employed 
Nr5a2f/f mice crossed with animals expressing Cre-recombinase from the anti-Müllerian 
hormone receptor-211 (Amhr2Cre/+; generous gift of Dr. Richard Behringer), generating 
granulosa-specific Nr5a2 mutant in primary follicles (Nr5a2Amhr2-/-). The litters were 
genotyped (see Supplemental Table II for primers) using DNA extracted from a biopsy of 
the tail. The non-mutant littermates were used as control groups, i.e., Nr5a2f/ftgCyp19+/+ 
and Nr5a2f/fAmhr2+/+ (respectively to the Nr5a2Cyp19-/- and Nr5a2Amhr2-/-).  
Estrous cycle and superstimulation protocol 
For estrous cycle staging, vaginal smears were collected daily (0900) with 
phosphate-buffered saline (PBS) 1x; smears were placed on glass slides and cytology was 
evaluated under the microscope (reviewed in Chapter 5). For superstimulation, 25 to 27-
day-old immature female mice, both Nr5a2Cyp19-/- and control were injected intraperitoneal 
(IP) with 5 IU of equine chorionic gonadotropin (eCG) (Folligon®, Intervet, Whitby, ON, 
Canada) to stimulate follicular development, followed by the injection of 5 IU of human 
chorionic gonadodotropin (hCG) (Chorulon®, Intervet, Whitby, ON, Canada) 44 to 48 h 
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post eCG, to induce ovulation. Ovaries and blood (collected by cardiac puncture) were 
collected at 12 h, 18 h or 24 h post hCG; ovaries were either snap frozen in liquid nitrogen 
and stored at -80oC for RNA or fixed in paraformaldehyde (PAF) 4% (Sigma-Aldrich) and 
embedded in paraffin for histological examination. Ovulated cumulus-oocyte complexes 
were collected from oviducts at 16 h post hCG injection and counted. Pure granulosa and 
cumulus cells were collected from Nr5a2Cyp19-/- and control at 12 h post hCG for the 
detection of Nr5a2 by qPCR and immunoblotting; these cells were isolated by puncturing 
both ovaries with 25G5/8" needles in PBS 1x, treating with hyaluronidase (from bovine 
testes, Sigma) and filtered (BD Falcon, Cell Strainer, 40 µm Nylon, Mexico) to remove the 
oocyte. At 4 h post hCG, pure granulosa and cumulus cells were isolated from Nr5a2Cyp19-/- 
and Nr5a2Amhr2-/- and their respective control females for RNA analysis.   
Breeding trials 
 For breeding assays, 8-week-old	  Nr5a2Cyp19-/- and control females were housed with 
reproductively proven C57BL/6 males for 6 months. Cages were inspected daily, and 
parturition dates and litter sizes were recorded. Another group of 8-week-old	  Nr5a2Cyp19-/- 
females was housed with C57BL/6 males, while control females were housed with 
vasectomized males for 40 days to establish the frequency of mating. The occurrence of 
copulatory plugs was verified by visual examination at 9:00 a.m. each day. For 
vasectomies, male mice were anesthetised by injection of Ketamine (100 mg/kg; Bioniche 
Animal Health, Belleville, ON, Canada) and Xylazine (10 mg/kg; Bayer Inc., Toronto, ON, 
Canada) then an incision of 1 cm through the skin along the midline of the lower abdomen 
was made, and 1 cm of vas deferens on each side was removed. Two weeks later, the 
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sterility of the vasectomized males was confirmed by housing with fertile females and 
subsequent observation of the absence of pregnancy for 60 days. For analysis of 
progesterone, adult (> 60 days of age) Nr5a2Cyp19-/- and control females were bred to males 
of proven fertility. Animals were examined daily at 9:00 a.m. for copulatory plugs, and the 
day that a plug was found was designated day 1 post coitum (dpc). Animals were 
terminated at 5.5 dpc for morphological analysis of the uterus and ovaries, and blood was 
collected for progesterone radioimmunoassay. 
RNA isolation and real time polymerase chain reaction (qPCR) 
Total RNA from ovary, liver and granulosa/cumulus cells was extracted with 
RNeasy® Mini Kit (Qiagen) as per manufacturer’s instructions; adipose tissue total RNA 
was extracted by using the RNeasy® Lipid Tissue Midi Kit (Qiagen). Reverse transcription 
was performed with the SuperScript® II First Reverse Transcriptase (Invitrogen) and 
random hexamer primers. Real-time quantitative PCR (qPCR) was performed using Power 
SYBR® Green PCR Master Mix (Applied Biosystems, Warrington, UK),	   with the 7300 
real-time PCR system (Applied Biosystems, Foster City, CA, USA).	   A common thermal 
cycling parameter (2 min at 50°C, 10 min at 95°C, then 40 cycles of 15 s at 95°C and 60 s 
at 60°C) was used to amplify each transcript. Melting curve analyses were performed to 
verify product identity, adding a dissociation step to the PCR run (15 s at 95°C, 60 min at 
60°C, 15 s at 95°C, and 15 s at 60°C). The sequences of the primers used are listed in 
Supplemental Table II, each was used in a final concentration of 3000 nM. Primers were 
validated by standard curves. Samples were run in triplicate and results were expressed 
relative to the ribosomal protein S18 (RPS18) levels. Data were then normalized to a 
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calibrator sample using ΔΔCt method, as described by Pfaffl18, with correction for 
amplification efficiency by LinRegPCR 11.0 software (Academic Medical Center, 
Amsterdam, the Netherlands).  
Immunoblotting  
Total protein was extracted with 25µg lysis buffer from granulosa/cumulus cells, 
separated on 10% SDS-PAGE, and subsequently transferred to a PVDF membrane. The 
membrane was blocked using 0.5% non-fat milk in Tris buffered saline containing 0.1% 
Triton-X (TBST) for 1 h at room temperature, incubated with rabbit polyclonal Nr5a2 
(Abcam, ab18293), diluted 1:500 in blocking solution overnight at 4°C, and then incubated 
in horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G (IgG; 
Santa Cruz Biotechnology) diluted 1:50,000 in TBST for 1 h at room temperature. Proteins 
were visualized by chemiluminescence (Immobilon Western, Millipore Corporation, 
Billerica, MA). Subsequently, membranes were washed in TBST, blocked as above, and 
incubated with HRP conjugated anti-mouse-β-actin (Santa Cruz Biotechnology), diluted 
1:80,000 in blocking solution for 20 minutes at room temperature. The optical density of 
bands detected at the expected molecular weight for Nr5a2 and β-actin was quantified by 
the Image Processing and Analysis in Java (ImageJ) software. The ratio of Nr5a2 and β-
actin densities was calculated for each sample.  
Immunofluorescence 
For histological examination, ovaries were fixed in PAF 4% overnight, then washed 
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in PBS 1x and paraffin embedded. Ovarian cell-specific localization of Nr5a2 and Scarb1 
was verified by fluorescence immunohistochemistry. Briefly, paraffin sections of ovaries 
were rehydrated, boiled in 10 mM sodium citrate (pH 6) for 30 minutes, and cooled to room 
temperature (RT). Sections were blocked overnight with 5% bovine serum albumin (BSA; 
IgG-Free, Protease-Free; Jackson Immunoresearch Lab., Inc.) at 4oC. Samples were then 
incubated with Nr5a2 (Abcam, ab18293) or rabbit polyclonal anti-mouse Scarb1 (Novus 
Biologicals), both diluted 1:50 in PBS 1x with 5% BSA overnight at 4oC. As a negative 
control, some sections were incubated with 5% BSA only. Sections were washed and 
incubated with cyanine 3 (Cy3)-conjugated goat anti-rabbit IgG (Jackson Immunoresearch 
Lab., Inc.), diluted 1:400 in PBS 1x for 1 h at RT. Slides were then washed, and sections 
were counterstained with 4’,6-diamidino-2-phenylindole (DAPI, Sigma, MO), diluted 
1:1,000 in PBS 1x, for 5 min. Slides were mounted in Permafluor (Thermo Fisher 
Scientific). Ovarian distribution of Nr5a2 and Scarb1 was observed by Axio imager M1, 
Zeiss Microscopy.  
Hormone assays 
Radioimmunoassay for progesterone (serum) and estradiol-17β (serum and 
follicular fluid) concentrations were evaluated in single assays according to a protocol 
previously described11. The intra-assay coefficients of variation were calculated between 
duplicates ranged from 4 to 9%.  
Statistical analyses 
All data were analysed using JMP (Version 5.0.1a. SAS Institute Inc.) statistical 
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software. Differences between mutant and control mice for a single data point were 
determined by Student’s t-test. For data obtained at multiple time points or multiple 
genotypes, two-way analysis of variance and differences between individual means were 
determined by the JMP LSMeans Contrast test. All numerical data are represented as mean 
± SEM. Significant difference was recognized at p < 0.05. 
2.4. Results 
The reproductive performance of female Nr5a2 conditional knockout mice in 
granulosa cells of antral follicles  
The conditional knockout (cKO; Nr5a2Cyp19-/-) mouse model generated by crossing 
Nr5a2-floxed mice with mice expressing the Cre-recombinase driven by the aromatase 
promoter, i.e., the transgenic line tgCyp19a1Cre/+; 17, presented an efficient and tissue-
specific disruption of the Nr5a2 target gene as indicated by dramatically reduced mRNA 
abundance in ovarian granulosa cells from antral follicles, but not in the other organs 
expressing Nr5a2 (Figure 2.1A-C). Protein levels of Nr5a2 were also reduced in granulosa 
cells of the Nr5a2Cyp19-/- ovaries, as shown by immunoblotting (Figure 2.1D-E) and by 
immunofluorescence (Figure 2.1F-L). The temporal specificity of Nr5a2 downregulation in 
the Nr5a2Cyp19-/- ovarian sections was evident by depletion in granulosa cells of antral 
follicles (Figure 2.1I) but not in preantral follicles (Figure 2.1G), as expected. After a 6-
month breeding trial with reproductively proven males, the control group composed of 
intact littermates (Nr5a2f/f tgCyp19a1+/+) generated the expected frequency of litters per 
female and litter size, while no litters were born from the Nr5a2Cyp19-/- females (Figure 
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2.2A). Daily consecutive evaluation of the vaginal epithelium evidenced a normal pattern 
of estrous cyclicity of 4 to 5 days in Nr5a2Cyp19-/- females compared to the control group 
(Figure 2.2B), with no abnormally prolonged intervals, indicating that the inability of the 
Nr5a2 conditional knockout mouse model to produce pups is not due to an irregular estrous 
cycle.  
 
 
Figure 2.1 : Characterization of the granulosa-specific knockout mouse Nr5a2Cyp19-/-. (A) Relative 
abundance of Nr5a2 mRNA in granulosa cells of superstimulated immature females isolated by ovarian 
puncture (n = 4 per genotype) (p < 0.001). Relative abundance of Nr5a2 mRNA in the liver (B) and adipose 
tissue (C) of adult females (n = 5 per genotype) (p > 0.1). (D) Relative abundance of Nr5a2 protein in 
granulosa cells of superstimulated immature females by immunoblotting (p < 0.05). (E) Representative 
immunoblot. Immunofluorescence demonstrating the depletion of Nr5a2 protein in granulosa cells of the 
conditional knockout ovary exclusively in the antral follicle (I), but not in preantral follicles (G). (F, H) 
Positive control for fluorescent immunohistochemistry staining. (J) DAPI staining the nuclei; (K) negative 
control using BSA 5%; and (L) merged DAPI and Cy3. Bars = F, J, K, L (60 μm); G (40 μm); H, I (20 μm). 
TC, theca cells; PAF, preantral follicle; GC, granulosa cells; O, oocyte; AF, antral follicle; CC, cumulus cells. 
CON = control; solid bars (Nr5a2f/ftgCyp19+/+); cKO = conditional knockout, open bars (Nr5a2Cyp19-/-). 
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Figure 2.2 : Reproductive performance of granulosa specific Nr5a2Cyp19-/- female mice. (A) Six 
month breeding trial employing CON (n = 5) and cKO (n = 4) adult females housed with reproductively 
proven C57BL/6 males; (*) p < 0.001. (B) Representative vaginal smear profiles from CON (solid line) and 
cKO (dotted line) female mice showing a normal 4 to 5 day estrous cycle length for both genotypes. P, 
proestrus; E, estrus; M, metestrus; D, diestrus. 
 
Antral follicles lacking Nr5a2 in granulosa cells are anovulatory 
Although preantral and antral follicle formation was observed in Nr5a2Cyp19-/- 
ovaries (Supplemental Figure 2.1A-B), and cumulus expansion was stimulated by 
gonadotropin administration as seen at 12 h post hCG (Figure 2.3A-C), almost no cumulus-
oocyte complexes (COCs) were retrieved from the Nr5a2Cyp19-/- oviduct 16 h after hCG 
injection, unlike the superovulation induced in the control group (Figure 2.3D-F).   
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Figure 2.3 : Ovarian superstimulation promotes cumulus expansion but not ovulation in granulosa-
specific knockout female mice. (A) Bright field microscopy images of hematoxylin-eosin stained sections of 
ovaries from immature cKO mice superstimulated with eCG and hCG and collected at 12 h post hCG. Bar = 
100 µm. PAF, preantral follicle; AF, antral follicle; CC, cumulus cells; O, oocyte. (B) Arrow indicates 
expanded cumulus cells at 12 h post hCG in cKO follicle. Bar = 40 µm. (C) Quantification of cumulus 
expansion by averaging the number of follicles containing expanded cumulus-oocyte complexes (COC) in 
CON and cKO ovarian sections at 12 h post hCG (n = 6 sections – from the middle of the ovary – per 
genotype) (p > 0.1). Ovulation rate (number of oocytes in the oviduct at 16 h post hCG) of CON (D; 10x 
magnification) and cKO (E; 40x magnification) immature female mice in response to superstimulation. (F) 
Mean number of oocytes in the oviduct in CON vs cKO mice. Different superscripts indicate significant 
differences at p < 0.001. 
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Analysis of ovarian granulosa and cumulus cells comparing our Nr5a2Cyp19-/- with 
the previously described Nr5a2Amhr2-/- mouse revealed that the pattern of gene expression 
differed between the two knockout models at 4 h post hCG (Figure 2.4A-F).  
 
 
Figure 2.4 : Abundance of mRNA as determined by qPCR for Pgr (A), Adamts4 (B), Adamts1 (C), 
Ptgs2 (D), Ldlr (E) and Cyp19a1 (F) relative to RPS18 comparing two granulosa-specific knockout mouse 
lines distinguished by the timing of Nr5a2 depletion during the follicular development. Superstimulated 
ovaries from immature females were collected at 4 h post hCG (n = 5 per group) and granulosa cells were 
isolated by ovarian puncture. Amhr2 (Cre-recombinase) = left bars, mutation in primary follicles, genotype 
Nr5a2Amhr2-/-; Cyp19 (Cre-recombinase) = right bars, mutation in antral follicles, genotype Nr5a2Cyp19-/-. CON 
= control; black bars (Nr5a2f/f tgCyp19+/+; or Nr5a2f/f Amhr2+/+); cKO = conditional knockout, gray bars 
(Nr5a2Cyp19-/- / or Nr5a2Amhr2-/-) respectively. Differing superscripts indicated differences at p < 0.05. 
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 The Pgr, which is essential for ovulation, showed decreased mRNA levels in both 
models (Figure 2.4A), whereas Adamts4 was downregulated in the Nr5a2Cyp19-/- model, but 
not in Nr5a2Amhr2-/- ovary (Figure 2.4B). For Adamts1, no difference in gene expression was 
seen between both conditional knockout models relative to their respective controls (Figure 
2.4C). Although there was no statistically significant difference for mRNA levels of the 
Ptgs2 (Figure 2.4D) and the low-density lipoprotein receptor (Ldlr) (Figure 2.4E), a 
tendency towards downregulation was observed in the granulosa cells of both Nr5a2Cyp19-/- 
and Nr5a2Amhr2-/-. Further, at 4 h post hCG, Cyp19a1 presented a tendency towards 
upregulation in the Nr5a2Amh2-/-, whereas it was downregulated in Nr5a2Cyp19-/- (Figure 
2.4F). These data indicate that Nr5a2 expression in granulosa cells of antral and 
preovulatory follicles is not essential for cumulus expansion but it is essential for ovulation. 
Antral expression of Nr5a2 is required for the formation of a functional corpus 
luteum  
We then investigated the role of Nr5a2 in luteinization using standard hormonal 
superstimulation in immature mice and analyzing the ovaries at later time points following 
the ovulatory stimulus (Figure 2.5A-E). At 12 h, 18 h and 24 h post hCG, when corpora 
lutea are normally abundant in the control ovary (Figure 2.5A-B), we identified the 
formation of luteal-like structures (LS) in Nr5a2Cyp19-/- ovarian sections. These structures 
appeared to be comprised of theca cells invading the follicles, and the follicles often 
contained a trapped oocyte (Figure 2.5C-D). The number of luteal-like structures in 
Nr5a2Cyp19-/- ovaries was significantly lower than the number of corpora lutea found in the 
control ovarian sections (n = 16 sections analyzed per group) (Figure 2.5E) at 12 h, 18 h or 
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24 h post hCG. We then asked whether the luteal-like structures were functional. During a 
40-day breeding trial, adult Nr5a2Cyp19-/- females were mated with reproductively proven 
males, and control females were mated with vasectomized males to establish the frequency 
of mating by examining copulatory plugs. The Nr5a2Cyp19-/- females showed frequent and 
irregular mating (mean interval, 3.67±0.21 days) compared to the control group 
(10.38±0.51 days), indicating the absence of a persistent pseudopregnant CL in   
Nr5a2Cyp19-/- females compared to the control mice. To determine whether the Nr5a2Cyp19-/- 
luteal-like structures could promote normal circulating levels of progesterone, adult 
Nr5a2Cyp19-/- and control females were bred to fertile males, examined for copulatory plugs 
and euthanized 5.5 dpc (Figure 2.5G-J). By this time of expected early post-implantation 
gestation, we found shorter uterine horns in Nr5a2Cyp19-/- (Fig. 2.5H), in contrast to the 
elongated pregnant control uterus (Figure 2.5G). Although luteal-like structures were 
observed in the Nr5a2Cyp19-/- ovaries (Figure 2.5J), they were fewer than the normal number 
of corpora lutea in the control ovaries (Figure 2.5I) and extremely low progesterone 
concentrations were detected in Nr5a2Cyp19-/- serum at 5.5 dpc (Figure 2.5K), whereas 
equivalent levels of serum and intra-follicular estradiol-17β were identified in Nr5a2Cyp19-/- 
females compared to the control levels (Supplemental Figure 2.1C-D). Insufficiency of the 
Nr5a2Cyp19-/- luteal-like structures was confirmed by reduced circulating concentrations of 
progesterone in the Nr5a2Cyp19-/- serum relative to control mice at 12 h, 18 h or 24 h post 
hCG (Figure 2.5L).  
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Figure 2.5 : Nr5a2 is important for the formation of a normal corpus luteum. (A-D) Bright field 
microscopy images of hematoxylin-eosin stained sections of ovaries from immature control and Nr5a2Cyp19-/- 
mice superstimulated with eCG / hCG and collected at 18 h post hCG. (A) Overview of the control ovary 
containing several corpora lutea. Bar = 100 µm. (B) A single corpus luteum (CL) from a control ovarian 
section. Bar = 40 µm. (C) General overview of the Nr5a2Cyp19-/- ovary containing one luteal-like structure 
(LS). Bar = 100 µm. (D) Nr5a2Cyp19-/- luteal-like structure showing an entrapped oocyte (O) indicated by the 
arrow. Bar = 40 µm. (E) Quantification of luteinization by averaging the frequency of luteal formation in 
control and Nr5a2Cyp19-/- ovarian sections at 12 h, 18 h and 24 h post hCG (n = 5 sections per genotype) (p < 
0.001). (F) Mating frequency comparing adult control and Nr5a2Cyp19-/- females during a 40-day breeding 
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trial. Control females were housed with vasectomized C57BL/6 males and Nr5a2Cyp19-/- females were housed 
with reproductively proven C57BL/6 males. Black squares indicate the observation of a copulatory plug, with 
short and irregular intervals between plugs for Nr5a2Cyp19-/- females, whereas the control group averaged 10 to 
13 days interval between plugs; p < 0.0001. Ovaries (OV) and uteri of control (G) and Nr5a2Cyp19-/- (H) adult 
females housed with a reproductively proven C57BL/6 male and collected at day 5.5 post coitum. (G) 
Elongated uterine horns containing implantation sites (indicated by the arrows) and the presence of several 
corpora lutea (CL) in the hematoxylin-eosin stained ovary (I) represents the control female reproductive 
system under the influence of the progesterone. A few luteal-like structures (LS) are found in the 
hematoxylin-eosin stained sections of the Nr5a2Cyp19-/- ovaries (J). Bars = G, H (4 mm); I, J (40 μm). Plasma 
progesterone concentrations in control and Nr5a2Cyp19-/- adult female mice at 5.5 dpc (K) and in immature 
superstimulated female mice at 12 h, 18 h and 24 h post hCG (p < 0.001). 
 
Based on the progesterone levels found after superstimulation, we then combined 
the eCG / hCG protocol with the 5.5 dpc scheme to check whether superstimulation would 
promote appropriate synthesis of progesterone in adult females after mating. Whilst control 
females were pregnant at 5.5 dpc (Supplemental Figure 2.2A), no implantation sites were 
observed in the Nr5a2Cyp19-/- uterine horns (Supplemental Figure 2.2B) and progesterone 
was consistently low in Nr5a2Cyp19-/- serum compared to progesterone concentrations in 
control females (Supplemental Figure 2.2C). We conclude that depletion of Nr5a2 in 
granulosa cells from the antral follicle stage results in luteal-like structures that are 
insufficient to promote normal serum levels of progesterone. 
The expression pattern of luteinization-related genes driven by Nr5a2 in 
preovulatory follicles 	  
To explore the abundance of transcripts of genes essential for cholesterol supply and 
progesterone synthesis in granulosa cells in response to LH stimulation, immature females 
were treated with eCG / hCG and whole ovaries were collected at 12 h, 18 h or 24 h post 
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hCG (Figure 2.6A-F). The relative abundance of Scarb1 mRNA was markedly reduced 
beginning at 18 h and continuing through 24 h post hCG in the Nr5a2Cyp19-/- group 
compared to the controls (Figure 2.6A). The abundance of Ldlr, Star and Cyp11a1 was 
lower in Nr5a2Cyp19-/- ovaries at 18 h post hCG, while at 12 h and 24 h there was a tendency 
of downregulation for these genes (Figure 2.6B-D). This notwithstanding, the strength of 
the mRNA signal for Hsd3β and Cyp19a1 showed increased expression in control mice 
over 12 h post hCG, but the expression was not altered by the depletion of Nr5a2 in 
granulosa cells of antral follicles at 18 h and 24 h (Figure 2.6E-F). We then examined the 
expression of Scarb1 in ovarian sections by immunofluorescence to determine whether the 
luteal-like cells were indeed luteinized granulosa cells (Figure 2.6G-H). In Nr5a2Cyp19-/- 
ovaries, luteal-like structures have an apparent higher signal of Scarb1 than granulosa cells 
in the same sections (Figure 2.6H), but the protein expression appears substantially lower 
than in the normal corpus luteum of control animals (Figure 2.6G). These data demonstrate 
that the deficient luteinization resulting from the absence of Nr5a2 in preovulatory follicles 
is related to the compromised expression of certain genes, mainly those involved in 
cholesterol transport. 
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Figure 2.6 : Pattern of expression as determined by qPCR for genes related to steroidogenesis at 
intervals around the time of and after expected ovulation. Relative abundance of mRNA of Scarb1 (A), Ldlr 
(B), Star (C), Cyp11a1 (D), Hsd3β (E) and Cyp19a1 (F) in whole ovaries of superstimulated immature 
females collected at 12 h, 18 h or 24 h post hCG (n = 5 per group) comparing control and Nr5a2Cyp19-/- (p < 
0.05) groups. Merged microscopy images of fluorescent immunohistochemistry of Scarb1 in ovarian sections 
of control (G) and Nr5a2Cyp19-/- (H) adult females. CL, corpus luteum; AF, antral follicle; LS, luteal-like 
structure. Bar = 50 µm. Panel G insert: negative control with 5% BSA using DAPI to stain the nuclei. 
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2.5. Discussion 
From the time of its discovery in Drosophila23; 7 to our present state of knowledge, 
the orphan nuclear receptor Nr5a2 has not only been designated by multiple names – liver 
receptor homolog-1, LRH-1, α-fetoprotein transcription factor, FTZ-F1-related factor and 
CYP7A1 promoter binding factor, among others – but it has been recognized to have an 
immense range of functions in both vertebrate and invertebrate models. Nr5a2 is expressed 
in steroidogenic tissues9, and its strong granulosa-specific expression has led to 
investigation of its role in reproduction, especially in the ovary4; 33; 19. More recently, it has 
been shown to be an important regulator in the mouse endometrium, to be essential for 
successful gestation37, and it appears to be upstream to regulation of gonadotropin secretion 
in the hypothalamus3.  
Nr5a2 is necessary for proper embryonic primitive streak formation, thus preventing 
early embryo survival in the mouse22, precluding study of its germline mutation in postnatal 
animals. Employing a mouse line with loxP sites flanking the third and fourth exons of 
Nr5a2 gene, and taking advantage of the Cre-loxP system has allowed in depth exploration 
of Nr5a2 in the ovary in recent years. By the use of a Cre-recombinase mouse line guided 
by Amhr2 (Nr5a2Amhr2-/-), it was shown that Nr5a2 is essential for cumulus expansion, 
ovulation and female fertility11. A later study on the role of Nr5a2 in reproduction applied 
the Cre-recombinase mouse line guided by the Pgr (Nr5a2Pgr-/-), which was responsible for 
depleting Nr5a2 during the late peri-ovulatory period in follicles and in the uterus, resulting 
in successful ovulation, formation of small but functional corpora lutea and infertility due 
to compromised endometrial decidualization37.  
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 In the present study we employed a third model with a different temporal pattern of 
depletion of Nr5a2. Mating with the Cyp19a1 Cre-recombinase mouse line (Nr5a2Cyp19-/-) 
resulted in excision of Nr5a2 from the antral follicle forward in the follicle development 
trajectory17. Females were infertile with an ovarian phenotype distinct from the two 
previous models, demonstrating another variant reproductive profile for conditional 
knockout mice lines in these studies. Our Nr5a2Cyp19-/- mouse model confirms that Nr5a2 is 
essential for ovulation with COCs almost completely absent in Nr5a2Cyp19-/- female oviducts 
following treatment with an ovulation induction protocol. This indicates that expression of 
Nr5a2 in antral follicles is required to provide the necessary ovulatory signals. The 
Nr5a2Pgr-/- mouse model demonstrates that ovulation is independent of Nr5a2 after 
approximately 4 h following the ovulatory stimulus, as these animals showed normal 
ovulatory rates37.   
Although the non-ovulatory phenotype is present in both the Nr5a2Cyp19-/- and the 
Nr5a2Amhr2-/- mouse models, one interesting difference between them is that cumulus 
expansion is absent when Nr5a2 is depleted in primary follicles in the Nr5a2Amhr2-/- 
mouse11, whereas the presence of Nr5a2 in preantral follicles is able to promote cumulus 
expansion in the Nr5a2Cyp19-/- females. This phenotype of cumulus expansion without 
ovulation is similar to that found in the progesterone receptor knockout (PRKO) mouse. 
Granulosa cells from preovulatory follicles of mice in the PRKO are responsive to the LH 
surge, demonstrated by the presence of expanded cumulus cells24, but Pgr is essential for 
LH-induced follicular rupture leading to ovulation2. In the present investigation, Nr5a2 
depletion in either the Nr5a2Cyp19-/- model or the Nr5a2Amhr2-/- is accompanied by significant 
downregulation of Pgr. This suggests that Nr5a2 is upstream of the Pgr gene, and regulates 
ovulation as a transcription factor to activate the critical progesterone receptor pathway. 
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The progesterone receptor, in turn, is an important regulator of the transcription of 
other genes linked to ovulatory success, including Adamts116. At 4 h post hCG the Adamts1 
levels are normal for both Nr5a2Amhr2-/- and Nr5a2Cyp19-/- ovaries. However, at 12h post hCG 
a downregulation of Adamts1 occurs in Nr5a2Cyp19-/- (data not shown), while in the 
Nr5a2Amhr2-/- ovaries normal levels are still observed11. While this could be related to the 
different cumulus expansion profiles in these two mouse models, other pathways may also 
be involved. The pattern of abundance of the Adamts4 transcript also differs between the 
two granulosa-specific knockout models; while it is downregulated in Nr5a2Cyp19-/- ovaries, 
it is normally expressed at 4 h post hCG in the Nr5a2Amhr2-/- ovaries. While Adamts4 is 
closely related to Adamts1, with some distinct and overlapping functions, it does not appear 
to be a target for the progesterone receptor30.   
Although the progesterone pathway seems to be regulated by Nr5a2, the expression 
of Ptgs2, a marker of follicular commitment to ovulation following the LH peak34, appears 
to be normal in the PRKO mice32, whereas Ptgs2 tends to be downregulated in both 
Nr5a2Cyp19-/- and Nr5a2Amhr2-/- models. Thus the complex phenotypes resulting from 
depletion of Nr5a2 in granulosa cells at different stages of follicular maturation strongly 
indicate that Nr5a2 regulates multiple pathways of female fertility. Further evidence that 
Nr5a2 regulates multiple pathways can be found in the observation that, despite the failure 
to ovulate, luteinization proceeds normally in the PRKO mice32, but not in our models 
lacking Nr5a2 in granulosa cells.  
In our previous studies using Nr5a2Amhr2-/- and Nr5a2Pgr-/- models, although they 
suggested that Nr5a2 has a role in ovarian luteinization11; 37, the time of depletion of the 
gene was either very early in the follicular development or after the LH peak. In the 
Nr5a2Amhr2-/- model, the lack of Nr5a2 in granulosa cells in primary follicles prevents 
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corpus luteum formation11. In the Nr5a2Pgr-/- model, albeit at reduced size, corpora lutea 
were formed in the Nr5a2Pgr-/- ovaries37, and this formation is probably due to the 
persistence of Nr5a2 expression in luteal cells for at least 4 h post hCG, when Cre-
recombinase resumes Nr5a2 depletion in this model. The compromised corpus luteum in 
the Nr5a2Pgr-/- ovaries indicates the importance of Nr5a2 up to later stages of the 
luteinization, but this model does not provide information on the role of Nr5a2 in early 
period of luteinization, due to persistence of Nr5a237. Our Nr5a2Cyp19-/- model is probably 
the best currently available to allow insight into the early luteal regulation of Nr5a2.  
Therefore, with the Nr5a2Cyp19-/- model we provide valuable information on the role 
of Nr5a2 in corpus luteum formation, as the time of Nr5a2 excision in granulosa cells of 
antral follicles is guided by the Cyp19a1 expression, which appears before the LH peak in 
the ovary17. Yet, our granulosa-specific Nr5a2Cyp19-/- knockout mice present a luteal-like 
formation in the ovaries, which is apparently comprised of luteinized theca cells 
surrounding granulosa cells. These structures were present in adult and immature 
superstimulated females. Although the number of these structures is reduced if compared to 
the normal number of corpora lutea in the control group, they appear able to generate some 
circulating levels of progesterone after hormonal superstimulation, but this secretion did not 
persist in adult females to 5.5 dpc. During a 40-day breeding trial, control females became 
pseudopregnant following a sterile mating. In the mouse pseudopregnancy, the surge of 
prolactin and the progesterone producing by the corpora lutea prevent the LH peak; with 
increased secretion of prostaglandin (PGF2α) in the absence of embryos, progesterone 
starts to reduce and females resume the estrous cycle10, making an expected interval of 10 
to 13 days between copulations. The frequent and irregular interval between copulations in 
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the Nr5a2Cyp19-/-, indicating the return to estrus, confirms the non-functionality of the luteal-
like structures to produce the necessary progesterone amount to promote pseudopregnancy.  
At the molecular level, luteinization in Nr5a2Cyp19-/- mice appears to be impaired by 
disruptions in the cholesterol supply and transport of proteins. Of importance is the 
downregulation of Scarb1. This factor is responsible for mediating the selective uptake of 
cholesterol from HDL, the principal source of cholesterol supply in the mouse ovary21. We 
have shown that ablation of Scarb1 results in defective intake of the precursor cholesterol 
into the granulosa-derived luteal cells1. Ldlr is also downregulated in the Nr5a2Cyp19-/- 
ovaries. The expression of other genes known to be necessary for steroidogenesis was also 
disrupted, including Star, the protein that governs the transport of cholesterol from the 
outer to inner mitochondrial membrane8 and CYP11a1, which is involved in the conversion 
of cholesterol to pregnenolone. The transcript for the next enzyme in the synthetic pathway, 
the Hsd3β, is upregulated earlier after ovulation, perhaps to compensate for the 
downregulation of the previous steroidogenic steps.  
In conclusion, our findings demonstrate that Nr5a2 regulates ovulation and female 
fertility differently but consistently in granulosa cells across the trajectory of follicular 
development (Figure 2.7). The progesterone receptor pathway seems to be the immediate 
downstream target for Nr5a2 activity in ovulation. The inadequate luteal function can be 
attributed, at least in part, to the disruption of the cholesterol transport pathways, although 
other pathways are also affected.   
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Figure 2.7 : Summary of the Nr5a2 functions in the ovary: lessons from the three different 
conditional knockout mouse models. (A) Diagram of normal follicular maturation in the mouse ovary. 
Primary follicles (1) have one layer of granulosa cells around the oocyte, acquiring new layers during 
follicular development; secondary follicles (2) will develop to antral follicles (3), when granulosa cells 
differentiate into mural and cumulus cells. When the LH peak occurs (4), immediate changes happen in the 
follicle (5) including cumulus expansion (6), ovulation (7) and luteinization (8). (B) By the Cre-loxP system, 
flanking the 3rd and 4th Nr5a2 exons and using the Amhr2-Cre recombinase, Nr5a2 is excised at the primary 
follicle stage, which does not affect folliculogenesis; on the other hand cumulus expansion, ovulation and 
luteinization are absent. (C) Excising Nr5a2 at the antral follicle stage before the LH peak, by the use of the 
Cyp19-Cre recombinase, both folliculogenesis and cumulus expansion are observed, but ovulation is 
impaired; luteinization is abnormal and oocytes are trapped in the luteal-like formations. (D) Excising Nr5a2 
at the antral follicle stage after the LH peak, by the use of the Pgr-Cre recombinase, the aberrant ovarian 
phenotype is restricted to the formation of reduced size corpora lutea, but folliculogenesis, cumulus expansion 
and ovulation occur normally. 
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2.6. Supplemental material  
TABLE II : List of primers used in these studies for both genotyping and qPCR. All 
primers are 5’ to 3’. 
 
 
 
 
Table 1 – List of pr mers used in these studies for both genotyping and qPCR. All primers are 5’ 
to 3’. 
 
Primer Forward Reverse 
Genotyping 
Nr5a2-flox GCTATAGGGAGTCAGGATACCATGG GTTCGTACCACTTTCATCTCCTCACG 
Cyp19a1-Cre ACTTGGTCAAAGTCAGTGCG CCTGGTGCAAGCTGAACAAC 
Amhr2-Cre GAACCTGATGGACATGTTCAGG AGTGCGTTCGAACGCTAGAGCCTGT 
qPCR 
RPS18 GTGGTGTTGAGGAAAGCAGACA TGATCACACGTTCCACCTCATC 
Adamts1 TAAGTGTGGCGTTTGTGGAG CCCTTTGATTCCGATGTTTC 
Adamts4 TCAACACCCCTAACGACTCA TGCATGGCTTGGAGTTATCA 
Cyp11a1 CTGCCTCCAGACTTCTTTCG TTCTTGAAGGGCAGCTTGTT 
Cyp19a1 ATGTTCTTGGAAATGCTGAACCC AGGACCTGGTATTGAAGACGAGC 
Hsd3β GGTTTTTGGGGCAGAGGATCA GGTACTGGGTGTCAAGAATGTCT 
Ldlr AATGGTGGTTGCCAGTACCT CCCTGGGTGGTCAGTACAGT 
Nr5a2 TCATGCTGCCCAAAGTGGAGA TGGTTTTGGACAGTTCGCTT 
Ptgs2 ATCCTGAGTGGGGTGATGAG AAGTGGTAACCGCTCAGGTG 
Pgr AGGTCTACCCGCCATACCTT CAGGTAAGCACGCCATAGTG 
Scarb1 TTGGCCTGTTTGTTGGGATG GGATTCGGGTGTCATGAAGG 
Star TTGGGCATACTCAACAACCA GCGGTCCACAAGTTCTTCAT 
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Supplemental Figure 2.1 : Follicle classes and estradiol-17β levels in Nr5a2Cyp19-/- mice. (A) 
Quantification of folliculogenesis by averaging the number of preantral and antral follicles in control and 
Nr5a2Cyp19-/- ovarian sections at 12 h post hCG (n = 5 sections per genotype) (p < 0.5). (B) Bright field 
microscopy image of hematoxylin-eosin stained ovarian section from immature Nr5a2Cyp19-/- mice 
superstimulated with eCG / hCG and collected at 12 h post hCG, showing the formation of preantral (PAF) 
and antral (AF) follicles. Bar = 50 µm. Estradiol-17β concentrations in the follicular fluid (C) and serum (D) 
of control and Nr5a2Cyp19-/- adult females at 5.5 dpc (p > 0.1). 
  
 
Supplemental Figure 2.2 : Breeding trial combining superstimulation and mating using Nr5a2 
granulosa specific knockout female mice. At 5.5 dpc, control superstimulated females showed implantation 
sites confirming pregnancy, represented by the ovaries and elongated uterine horns (A), while their absence in 
Nr5a2Cyp19-/- (B) females confirms their infertility and short uterine horns phenotypically representing the low 
levels of progesterone. Bars = 2 mm. (C) Plasma progesterone concentrations from control and Nr5a2Cyp19-/- 
adult superstimulated female mice at 5.5 dpc. 
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3.1. Abstract 
The orphan nuclear receptor Nr5a2, a.k.a. liver receptor homolog-1, is expressed in 
granulosa, cumulus and luteal cells of the mouse ovary, and it is a key modulator of female 
fertility. Conditional knockout mice with depletion of Nr5a2 in ovarian granulosa cells 
from primary follicles onward exhibited disrupted cumulus expansion.  In contrast, mice 
with depletion of Nr5a2 in granulosa cells from antral follicles onward undergo cumulus 
expansion after hormonal superstimulation. We hypothesized that Nr5a2 modulates 
cumulus expansion in a spatiotemporal manner. We employed the two previously described 
granulosa-specific knockout mouse models genotyped as: 1) Nr5a2Amhr2-/-, bearing Nr5a2 
depletion from preantral follicles; and 2) Nr5a2Cyp19-/-, bearing Nr5a2 depletion from antral 
follicles. Cumulus expansion occurred spontaneously in Nr5a2Cyp19-/- females at 
approximately 12 h after the endogenous LH peak. Nr5a2 is depleted in mural granulosa 
cells of the Nr5a2Cyp19-/- ovaries, but its expression is detected in their cumulus cells. To 
establish a comparison between the two mutant models for their cumulus expansion 
capability, an in vitro cumulus expansion assay was performed. Both Nr5a2Amhr2-/- and 
Nr5a2Cyp19-/- cumulus-oocyte complexes underwent expansion in vitro, but the degree of 
expansion was reduced relative to that observed in the controls at 12 h of culture. We 
evaluated the cumulus expansion-related genes regulated by Nr5a2 in both mutant strains in 
vivo and found downregulation of Areg, Ereg, Btc and Tnfaip6 gene expression at 2 h and 4 
h post hCG (p < 0.05). Protein expression of connexin 43 (Cx43; Gja1) was evaluated by 
immunofluorescence in the Nr5a2Amhr2-/- ovarian sections, and the intensity for Gja1 in 
granulosa and cumulus cells of the Nr5a2Amhr2-/- mutant follicles was lower at 0 h and 
maximum at 8 h post hCG, as opposed from the pattern of Gja1 protein expression 
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observed in control ovaries. The oocytes in both mutant genotypes can undergo germinal 
vesicle breakdown, confirming their capability to mature in vivo. To establish whether the 
oocytes are fertilizable, adult females Nr5a2Amhr2-/-, Nr5a2Cyp19-/- and control groups were 
hormonally synchronized and the oocytes presenting polar bodies were fertilized by ICSI. 
Subsequent observation indicated that approximately 70% of the resulting embryos were 
capable of proceeding to the blastocyst stage in vitro, independent of the genotype. We 
conclude that the cumulus cells of Nr5a2Cyp19-/- mice are able to expand more efficiently 
that the Nr5a2Amhr2-/- both in vivo and in vitro. Moreover, cumulus expansion-related gene 
expression is equally disrupted in both mutant models. The disruption of the Nr5a2 gene 
expression that occurs in the somatic cells of the follicle does not affect the capability of the 
oocytes to be fertilized.  
3.2. Introduction 
Within the ovary, follicular granulosa cells differentiate into mural granulosa cells 
and cumulus cells, working in reciprocal communication with the oocyte, the female germ 
cell17. Mural granulosa cells express aromatase, which is encoded by the cytochrome P450 
family 19 subfamily A polypeptide 1 (Cyp19a1)34 gene. Under the control of follicle-
stimulating hormone (FSH), aromatase converts the theca-derived androgens into 
estrogens, whereas estradiol-17β (E2) is the predominant aromatized estrogen. Estradiol-
17β regulates the proliferation of granulosa cells29, inducing the expression of LH receptors 
(LHR) and causing granulosa cells to become responsive to LH6.  
Cumulus granulosa cells within the preovulatory follicle are closely connected to 
the oocyte27. An acute peak of LH triggers the occurrence of important reproductive events 
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in the female, including the migration of the cumulus cells outwardly from the oocyte19, in 
a process known as cumulus expansion, critical for normal oocyte development, ovulation, 
and fertilization15. The LH stimulus induces a transient and sequential expression of the 
epidermal growth factor (EGF)-related factors, including epiregulin (Ereg), amphiregulin 
(Areg) and betacellulin (Btc) that have been recently identified as essential for oocyte 
maturation and cumulus expansion26.  
The peak of LH also induces the expression of other genes with a pivotal role in 
cumulus expansion, such as the hyaluronic acid synthase 2 (HAS-2)5, involved in the 
deposition of a hyaluronic acid matrix between the cumulus cells9. The entire ovulatory 
process involves inflammatory-like ovarian changes29, implying the importance of the 
prostaglandin-endoperoxide synthase-2 (PTGS2)32 and the tumor necrosis factor-stimulated 
gene-6 (Tnfaip6)18. Cumulus expansion is further complex, involving the regulation and 
modification of gap-junctional proteins12, such as the connexin 43 (gap junction alpha-1; 
GJA1)36. Several gene products of the follicular cells are required for successful and 
optimal ovulation, in a combined endocrine and paracrine intra-follicular communication31. 
Recently, it has been shown that the orphan nuclear receptor, Nr5a2, is essential for 
ovulation. A conditional knockout mouse model bearing a depletion of Nr5a2 in granulosa 
cells from primary follicles presented impaired cumulus expansion that could not be 
rescued by hormonal superstimulation14. On the other hand, another study of the role of 
Nr5a2 in later stages of the follicular development showed that granulosa-specific knockout 
females underwent cumulus expansion after a protocol of hormonal injection2. The lack of 
ovulation was consistent in both mutant models, but there is no evidence on whether the 
oocytes are affected by the disruption of Nr5a2 in somatic cells2; 14. Our objectives were to 
compare the cumulus expansion process using the two previously described Nr5a2 
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granulosa-specific knockout mice models, and to determine whether the expression of 
Nr5a2 in granulosa cells is essential for the oocytes to be fertilized. We hypothesize that the 
inconsistent pattern of cumulus expansion in both mice models is due to a distinct 
spatiotemporal depletion of Nr5a2.  
3.3. Materials and methods 
Animals and colony maintenance 
All animal experiments were approved by the University of Montreal Animal Care 
Committee and conducted according to the guidelines of the Canadian Council on Animal 
Care (CCAC) – Guide to the Care and Use of Experimental Animals. All mutant and 
control mice were of the C57BL/6 background. Animals were maintained under a 14:10 
light:dark cycle, provided food and water ad libitum. All euthanasia was performed by 
anesthetizing the animals with Isoflurane (PPC, Richmond Hill, ON, Canada) in a closed 
container, followed by cervical dislocation. Nr5a2 floxed (Nr5a2f/f) mice, generated by Dr. 
Johan Auwerx, have been described previously3. To generate granulosa-specific Nr5a2 
mutant in antral follicles, animals expressing Cre-recombinase from the cytochrome P450 
family 19 subfamily A polypeptide 1 (Cyp19a1 a.k.a. aromatase20) designated Cyp19a1Cre/+ 
were crossed with Nr5a2f/f mice; conditional knockout (cKO) genotype: Nr5a2Cyp19-/-. To 
generate granulosa-specific Nr5a2 mutant in primary follicles, we employed the previously 
described Nr5a2f/f mice crossed with animals expressing Cre-recombinase from the anti-
Müllerian hormone receptor-214 (Amhr2Cre/+; generous gift of Dr. Richard Behringer); cKO 
genotype: Nr5a2Amhr2-/-. The litters were genotyped (see Table III for primers) using DNA 
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extracted from a biopsy of the tail. The non-mutant littermates were used as control groups, 
i.e., Nr5a2f/ftgCyp19+/+ and Nr5a2f/fAmhr2+/+, respectively for the Nr5a2Cyp19-/- and 
Nr5a2Amhr2-/-.  
Superstimulation protocol 
For hormonal superstimulation, female mice both Nr5a2Cyp19-/-, Nr5a2Amhr2-/- and 
their respective controls were injected intraperitoneally (IP) with 5 IU of equine chorionic 
gonadotropin (eCG) (Folligon® – Intervet, Whitby, ON, Canada) to stimulate follicular 
development, followed by the injection of 5 IU of human chorionic gonadodotropin (hCG) 
(Chorulon® – Intervet, Whitby, ON, Canada ) 44 to 48 h post eCG, to induce ovulation. 
Ovaries were collected at the moment of the euthanasia in different time-points varying for 
each experiment; ovaries were either snap frozen in liquid nitrogen and stored at -80oC for 
RNA or fixed in paraformaldehyde (PAF 4%) (Sigma-Aldrich) and embedded in paraffin 
for histological examination.  
Estrous cycle and natural cumulus expansion 
Experimental design for the detection of natural cumulus expansion was made 
based on the mouse estrous cycle (as reviewed in the Chapter 5 of this thesis). For estrous 
cycle staging, vaginal smears were collected daily (at 09 00) with phosphate-buffered saline 
(PBS) 1x from adult 8-wk-old Nr5a2Cyp19-/- and control females; smears were placed on 
glass slides and cytology was evaluated under the microscope. The day when proestrus was 
detected, the female was moved to a cage with one C57BL/6 wild type (WT) male. The 
occurrence of the LH peak was confirmed by the presence of a copulatory plug verified by 
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visual examination in the morning of the next day (at 04 00), and euthanasia was performed 
at this time. The ovaries were fixed in PAF 4% and embedded in paraffin for histological 
examination by hematoxylin and eosin staining.  
Cumulus expansion assay 
 Immature female mice Nr5a2Cyp19-/-, Nr5a2Amhr2-/- and the controls were hormonally 
superstimulated with eCG and the cumulus-oocyte complexes (COCs) were collected by 
ovarian puncture at 40 h post eCG as previously described13. COCs were then cultured in 
25 µl drops of MEM-α (Invitrogen) supplemented with penicillin/streptomycin sulfate 
(Invitrogen), bovine serum albumen (BSA) 0.3% and bovine FSH (National hormone and 
peptide program, CA) at a density of 1 COC/µl and kept at 37oC incubation chamber 5% 
CO2 in humidified air. The expansion of the cumulus cells was evaluated at 0 h, 4 h, 8 h, 12 
h and 24 h of treatment in culture and the images were recorded by the Axio imager M1, 
Zeiss Microscopy. For co-culture experiments, 50 fully-grown denuded oocytes from WT 
females primed with eCG and collected at 44 h – 48 h post eCG were added to the drops 
containing the COCs as detailed above. Cumulus expansion was graded from 0 (no 
expansion) to 4 (full expansion) and the rates of expansion potential were calculated at 12 h 
of FSH treatment.  
RNA isolation and real time polymerase chain reaction (qPCR) 
Populations of granulosa and cumulus cells were collected from 25 to 27-day-old 
immature female mice Nr5a2Cyp19-/-, Nr5a2Amhr2-/- and their respective controls at 2 h or 4 h 
post hCG (as previously described hormonal superstimulation) for RNA analysis. The cells 
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were isolated by puncturing both ovaries with 25G 5/8" needles in PBS 1x, oocytes were 
separated from cumulus cells by up-and-down pipetting and removed from the final 
samples by filtering (BD Falcon, Cell Strainer, 40 µm Nylon, Mexico).	  Total RNA from 
granulosa/cumulus cells was extracted with RNeasy® Mini Kits (Qiagen) as per 
manufacturer’s instructions. Reverse transcription into cDNA was performed with the 
SuperScript® II First Reverse Transcriptase (Invitrogen) and random hexamer primers. 
Real-time qPCR was performed using Power SYBR® Green PCR Master Mix (Applied 
Biosystems, Warrington, UK),	  with the 7300 real-time PCR system (Applied Biosystems, 
Foster City, CA, USA).	  General PCR conditions (2 min at 50°C, 10 min at 95°C, then 40 
cycles of 15 s at 95°C and 60 s at 60°C) were used to amplify the product. Melting curve 
analyses were performed to verify product identity, adding a dissociation step to the PCR 
run (15 s at 95°C, 60 min at 60°C, 15 s at 95°C, and 15 s at 60°C). The sequences of the 
primers sets used are listed in Table III, each used in a final concentration of 3000 nM. 
Primers were validated by standard curves. Samples were run in triplicates and results were 
expressed relative to the ribosomal protein S18 (RPS18) levels. Data were then normalized 
to a calibrator sample using ΔΔCt method, as described by Pfaffl28, with correction for 
amplification efficiency by LinRegPCR 11.0 software (Academic Medical Center, 
Amsterdam, the Netherlands). 	  
Immunofluorescence 
For histological examination, ovaries were fixed in PAF 4% overnight, then washed 
in PBS 1x and paraffin embedded. Ovarian cell-specific localization of Nr5a2 and Gja1 was 
verified by fluorescence immunohistochemistry. Briefly, paraffin sections of ovaries were 
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rehydrated, boiled in 10 mM sodium citrate (pH 6) for 30 min, and cooled to room 
temperature (RT). Sections were blocked overnight with 5% bovine serum albumin (BSA) 
immunoglobulin G (IgG)-Free, protease-Free (Jackson Immunoresearch Lab., Inc.) at 4oC. 
Samples were then incubated with Nr5a2 (Abcam, ab18293) diluted 1:50 and rabbit 
polyclonal IgG connexin 43 (Gja1; Santa Cruz Biotechnology) diluted 1:100 both in PBS 
with 5% BSA overnight at 4oC. As negative control, some sections were incubated with 5% 
BSA only in place of the first antibody. Sections were washed, incubated with cyanine 3 
(Cy3)-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Lab., Inc.), diluted 1:400 
in PBS 1x for 1 h at RT. Slides were then washed, and sections were counterstained with 
4’,6-diamidino-2-phenylindole (DAPI, Sigma, St. Louis, MO), diluted 1:1000 in PBS, for 5 
min. Slides were mounted in Permafluor (Thermo Fisher Scientific, UK). Ovarian 
distribution of Nr5a2 and Gja1 was observed by Axio imager M1 (Zeiss Microscopy).  
Intracytoplasmic sperm injection (ICSI) 
Adult (8-wk-old) female mice Nr5a2Cyp19-/-, Nr5a2Amhr2-/- and controls were 
hormonally superstimulated and euthanasia was performed as previously described. COCs 
were collected from 5 females per genotype by ovarian puncture with 25G 5/8" needles at 
11 h post hCG. Cumulus cells were dispersed by incubating the COCs for 1 minute with 80 
units/ml of hyaluronidase (from bovine testes, Sigma), and the cells were removed 
pipetting gently. Oocytes were evaluated for the presence of a polar body (PB), indicating 
metaphase II maturation, and pooled together according to the genotype. For sperm 
collection, two WT male mice were euthanized and the sperm were collected from the 
cauda region of each excised epididymis. Sperm were incubated in one drop of modified 
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human tubal fluid (mHTF) containing 0.9% BSA for 90 min at 37oC in 5% CO2 in 
humidified air to induce capacitation. ICSI was conducted as previously described37. 
Briefly, 5 µl of sperm suspension were mixed with 5 µl of 12% polyvinylpyrrolidone 
(PVP) solution under oil. Oocytes were transferred from the mHTF medium to Hepes 
buffered mHTF medium under oil. By the means of a Nikon microscope (Eclipse) equipped 
with Narishige micromanipulators and a Piezo system (Prime Tech, Japan), the head of a 
morphologically normal and highly motile sperm was separated from the tail and injected 
into the oocyte (n = 25 injected oocytes per genotype). After injection, the oocytes were 
transferred into a 50 µl drop of embryo maintenance medium under oil and cultured at 5% 
CO2 in humidified air. Fertilization rate was assessed by cleavage of the survived oocytes 
24 h after ICSI, and embryonic development to morula stage was observed 96 h after ICSI. 
Blastocyst development was visualized at 120 h after ICSI. The rate of cleavage (2-cell) 
was based on the number of MII injected oocytes, and the rate of blastocyst development 
was based on the number of cleaved oocytes after ICSI.  
Statistical analyses 
All data were analysed using JMP (Version 5.0.1a. SAS Institute Inc.) statistical 
software. Differences between mutant and control mice for data obtained at multiple time 
points or multiple genotypes were determined by two-way analysis of variance followed by 
JMP LSMeans Contrast post hoc test to determine the differences between individual 
means. All numerical data are represented as mean ± SEM. Significant difference was 
recognized at p < 0.05.  
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3.4. Results 
Characterization of the cumulus cells profile in the Nr5a2Cyp19-/- ovaries 
The granulosa-specific knockout (cKO; Nr5a2Cyp19-/-) mouse model generated by 
crossing Nr5a2-floxed mice with the transgenic line tgCyp19a1Cre/+, expressing the Cre-
recombinase driven by the aromatase promoter, was evaluated for the occurrence of natural 
cumulus expansion in adults in vivo without ovarian superstimulation. Control and cKO 
Nr5a2Cyp19-/- females in proestrus were housed with a reproductively proven WT male, and 
the natural LH peak was confirmed by the visualization of a vaginal copulatory plug. At 
approximately 12 h after the assumed LH peak, ovarian histology showed the expected 
cumulus expansion in control females (Figure 3.1A), and that in adult Nr5a2Cyp19-/- ovaries 
(Figure 3.1B) cumulus expansion also happens naturally. To study the spatial depletion of 
Nr5a2 driven by aromatase, immature Nr5a2Cyp19-/- and control females were 
superstimulated and the ovaries were collected at 12 h post hCG (Figure 3.1C-F). 
Immunofluorescence showed that the protein levels of Nr5a2 were reduced in mural 
granulosa cells of Nr5a2Cyp19-/- ovarian follicles when compared to the control ovaries 
(Figure 3.1C), whereas the expression in cumulus cells is not depleted in the cKO (Figure 
3.1E,F). Thus, the depletion of Nr5a2 is more efficient in mural granulosa cells than in 
cumulus cells when the aromatase promoter drives Nr5a2-flox Cre-recombination. 
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Figure 3.1 : Characterization of cumulus cells in the granulosa-specific knockout mouse    
Nr5a2Cyp19-/-. Bright field microscopy images of hematoxylin-eosin stained sections of ovaries from adult 
CON (A) and Nr5a2Cyp19-/- (B) mice in estrus showing cumulus expansion. (C-F) Microscopic images of 
Nr5a2 immunofluorescence in ovarian sections. (C) Positive control for staining of granulosa and cumulus 
cells; (D) negative control using BSA 5%; (E) depletion of Nr5a2 protein in granulosa cells of the conditional 
knockout ovary exclusively in granulosa cells but not in cumulus cells; and (F) DAPI and Cy3 merged. CC, 
cumulus cells; TC, theca cells; GC, granulosa cells; O, oocyte. Bars = A (80 μm); B (40 μm); C-F (20 μm). 
CON = control (Nr5a2f/ftgCyp19+/+); Nr5a2Cyp19-/- = conditional knockout. 
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In vitro potential of cumulus expansion in two Nr5a2 granulosa-specific 
knockout mice models 
Females Nr5a2Cyp19-/-, Nr5a2Amhr2-/- and controls (n = 10 per group) were 
superstimulated and the COCs were collected at 40 h post eCG to evaluate their capacity of 
expansion in vitro. COCs were treated with FSH during 24 h in culture. Based on the 
negative control (Figure 3.2B) incubated in medium without FSH, the degree 0 (minimum) 
of expansion was determined. The maximum expansion for the control group (Figure 3.2A) 
occurred at 12 h of treatment, and it was rated as degree 4 of expansion. Based on the 
evaluation of the recorded images taken at 12 h of treatment for all the COCs, the 
expansion of the Nr5a2Amhr2-/- group (Figure 3.2C) was shown to be less efficient than in 
the control group. The expansion of the Nr5a2Cyp19-/- (Figure 3.2D) group was also 
compromised in vitro. Co-culture of the COCs showed that the expansion of the two mutant 
models Nr5a2Amhr2-/- (Figure 3.2E) and Nr5a2Cyp19-/- (Figure 3.2F) was not rescued by the 
presence of the WT oocytes. Quantification of the cumulus expansion resulted in an 
average of maximum expansion in the control group, and a compromised expansion in the 
two Nr5a2 knockout models, with the Nr5a2Amhr2-/- females presented the lower degree of 
cumulus expansion in vitro (Figure 3.2G).  
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Figure 3.2 : Expansion potential of cumulus-oocyte complexes from two granulosa-specific 
knockout mouse lines distinguished by temporal and spatial depletion of Nr5a2 during the follicular 
development. (A) Control (CON) females and (B) negative control without FSH (NC). (C) Cumulus-oocyte 
complexes of cKO Nr5a2Amhr2-/-; and (D) cKO Nr5a2Cyp19-/- at 12 h of in vitro incubation with FSH. (E-F) Co-
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culture of Nr5a2 granulosa-specific knockout cumulus-oocyte complexes with wild type oocytes; (E) cKO 
Nr5a2Amhr2-/- and (F) cKO Nr5a2Cyp19-/-. Panel F insert: negative control (NC) without FSH. Bar = 50 µm. (G) 
Quantification of cumulus expansion potential of control (CON), cKO Nr5a2Cyp19-/- and Nr5a2Amhr2-/-; (*) p < 
0.05.  
 
The expression pattern of cumulus expansion-related genes driven by Nr5a2 in 
preantral and preovulatory follicles 
Analysis of ovarian granulosa and cumulus cells of Nr5a2Cyp19-/- and Nr5a2Amhr2-/- 
mice revealed that the expression of cumulus expansion-related genes is compromised in 
both granulosa-specific knockout mouse models (Figure 3.3A-D). The pattern of gene 
expression at 2 h or 4 h post hCG showed a consistent downregulation in both time-points 
and for both mutant genotypes for the EGF-related factors Areg (Figure 3.3A), Ereg 
(Figure 3.3B) and Btc (Figure 3.3C). The Tnfaip6 (Figure 3.3D) also shows the same 
pattern of expression in all the groups. In contrast, histological analysis of hematoxylin and 
eosin stained ovaries indicated that the Nr5a2Cyp19-/- COCs (Figure 3.3F) revealed no 
apparent difference if compared to those found in the control group (Figure 3.3E) at 4 h 
post hCG. We conclude that Nr5a2 expression in granulosa cells of preantral or antral 
follicles modulates cumulus expansion by regulating important genes necessary for this 
event.  
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Figure 3.3 : Abundance of mRNA as determined by qPCR for (A) Areg, (B) Ereg, (C) Btc and (D) 
Tnfaip6 relative to RPS18 comparing two granulosa-specific knockout mouse models distinguished by the 
timing of Nr5a2 depletion during the follicular development; superstimulated ovaries from immature females 
were collected at 2 h or 4 h post hCG (n = 5 per group) and granulosa cells were isolated by ovarian puncture. 
Amhr2 (Cre-recombinase) = left bars, mutation in primary follicles. Cyp19 (Cre-recombinase) = right bars, 
mutation in antral follicles. CON = control, black bars (Nr5a2f/f tgCyp19+/+; or Nr5a2f/f Amhr2+/+); cKO = 
conditional knockout, white bars (Nr5a2Cyp19-/- / or Nr5a2Amhr2-/-) respectively. Differing superscripts indicated 
differences at p < 0.05. (E-F) Bright field microscopy images of hematoxylin-eosin stained sections of ovaries 
from (E) immature control (CON) and (F) cKO Nr5a2Cyp19-/- mice superstimulated with eCG and hCG and 
collected at 4 h post hCG. Bar = 100 µm. CC, cumulus cells; GC, granulosa cells. 
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Gja1 expression is dysregulated in Nr5a2Amhr2-/- ovarian granulosa and 
cumulus cells 
We examined the expression of the Gja1 in Nr5a2Amhr2-/- ovarian sections (Figure 
3.4A-H) by immunofluorescence to determine whether the more severe impairment in their 
cumulus expansion is related to a problem in cell-to-cell communication. In immature 
superstimulated Nr5a2Amhr2-/- ovaries at 0 h post hCG (Figure 3.4B,D), qualitative analysis 
of the Gja1 protein expression shows an apparent downregulation in granulosa and cumulus 
cells compared to the control group (Figure 3.4A,C). This pattern of protein 
downregulation is reversed in the cKO ovaries at 8 h post hCG (Figure 3.4 F,H), when a 
lower expression of Gja1 is expected to be normal in the control group (Figure 3.4E-G). 
Overall, Gja1 expression appears to decrease as follicles develop from 0 h to 8 h post hCG 
in the control ovaries, however in the cKO cells, the staining appear more intense at 8 h 
than at 0 h post hCG, suggesting that the communication between granulosa and cumulus 
cells is dysregulated in Nr5a2Amhr2-/- ovaries. 
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Figure 3.4 : Microscopic images of fluorescent immunohistochemistry of Gja1 (connexin 43; red; 
Cy3) in ovarian sections of CON and Nr5a2Amhr2-/- immature female mice superstimulated with eCG and hCG 
and collected at 0 h (A-D) or 8 h (E-H) post hCG, using DAPI to stain the nuclei (blue). CC, cumulus cells; 
TC, theca cells; GC, granulosa cells; O, oocyte. Bar = 40 µm. Panel B insert: negative control (NC) with 5% 
BSA. 
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The disruption of Nr5a2 in granulosa cells of preantral or antral follicles does 
not affect the oocyte fertilizability  
We found that 85% of the oocytes from both Nr5a2Cyp19-/- and Nr5a2Amhr2-/- cKO (n 
= 5 per group) exhibited polar body formation after 12 h post hCG injection (Figure 3.5A), 
in concordance with the results obtained in the control groups (data not shown). To 
establish whether the oocytes were fertilizable, adult females Nr5a2Cyp19-/- and Nr5a2Amhr2-/- 
cKO and control groups (n = 5 per group) were hormonally synchronized. At 12 h post 
hCG, oocytes presenting a polar body were fertilized by ICSI. Subsequent observation of 
the oocytes at 24 h post ICSI indicated that approximately 70% of the oocytes were 
fertilized and cleaved into 2-cell embryonic stage, independent of the genotype (Figure 
3.5B). Morula formation was observed at 96 h post ICSI in all the genotypes (Figure 3.5C), 
and the resulting embryos were capable of proceeding to the blastocyst stage (Figure 3.5D) 
in vitro in a rate of approximately 70% (Figure 3.5E) for both Nr5a2Cyp19-/- and Nr5a2Amhr2-/- 
cKO and the control groups. These data indicate that the expression of Nr5a2 in ovarian 
somatic cells is not essential for the ability of the oocyte to be fertilizable. 
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Figure 3.5 : The lack of Nr5a2 in granulosa cells does not compromise oocyte fertilizability. 
Microscopy image of (A) oocytes representing germinal vesicle breakdown (GVBD); (B) 2-cell embryo; (C) 
morula and (D) blastocyst of CON (control), conditional knockout Nr5a2Amhr2-/- and Nr5a2Cyp19-/- female mice. 
(E) Fertilization rate of CON, conditional knockout Nr5a2Amhr2-/- and Nr5a2Cyp19-/-. Black bars = percentage of 
mature oocytes (MII) reaching the 2-cell embryonic stage for each genotype; white bars = percentage of 2-cell 
embryos reaching the blastocyst stage for each genotype (p > 0.1). 
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3.5. Discussion 
The cumulus oophorus undergoes dramatic changes in morphology in response to 
gonadotropins, as it becomes expanded by the deposition of a hyaluronic acid matrix 
between the cumulus cells, culminating in ovulation9. Cumulus expansion is an essential 
process in ovulation, and in its absence, ovulation is impaired6. Previous work using mouse 
somatic targeted mutagenesis showed that the nuclear receptor Nr5a2 is a key regulator of 
the ovulatory process. The disruption of Nr5a2 in granulosa cells from primary follicles 
onward (Nr5a2Amhr2-/-) resulted in lack of cumulus expansion8. Recently, a complementary 
study applied the disruption of Nr5a2 from antral follicles onward (Nr5a2Cyp19-/-). This 
second mouse model also presented an anovulatory phenotype, but surprisingly showed 
that cumulus expansion was occurring after hormonal superstimulation2.  
Aiming to elucidate the role of Nr5a2 in peri-ovulatory events, we employed these 
two previously described mouse models in parallel, determining a comparative study about 
the role of nuclear receptor Nr5a2 in a time line sequence of follicular development. In this 
particular study, we focused on the role of Nr5a2 in cumulus oophorus cells. 
Hormonal protocols of ovarian superovulation are widely used in research with the 
mouse model. The protocol consists of one injection of eCG, inducing FSH activity14, 
followed by one injection of hCG, mimicking the LH peak10. This protocol is used to 
synchronize and superovulate female mice, and also to bypass potential pituitary deficiency 
in FSH and LH secretion. This artificial hormonal superstimulation was applied in the 
previous studies showing cumulus expansion in the Nr5a2Cyp19-/- model2. Therefore, it was 
deemed important to determine whether these females can spontaneously undergo cumulus 
expansion in vivo. 
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Based on multiple previous studies it was possible to approximate the occurrence of 
the natural LH peak by following the consistent mouse estrous cyclicity (Chapter 5). 
Taking into account the timeline of the cycle, ovulation takes place between 2330 and 0430 
of the estrus day16, at 12 to 14 hours after the surge of LH. A vaginal copulatory plug 
confirmed the female estrus phase, and by collecting the ovaries at 0400 we expected to 
visualize spontaneous cumulus expansion in ovarian histologic sections. Our estimative 
protocol was shown to be precise, since all of the control group presented cumulus 
expansion at that time. Our data demonstrated that Nr5a2Cyp19-/- females undergo cumulus 
expansion in nature, and that the LH peak is also occurring.  
Following confirmation that the Nr5a2Cyp19-/- model undergoes cumulus expansion 
and knowing that the Nr5a2Amhr2-/- does not, we hypothesized that the excision of Nr5a2 in 
these two models was not only temporally different, but also spatially different. We 
employed the Cre-loxP system to generate our two mouse models. In this system, Cre-
recombinase protein causes recombination of specific sequences of DNA with high 
fidelity13. It efficiently catalyzes site-specific DNA recombination between two loci of 
crossover (x) in P1 (loxP), inserted around a functionally essential part of the gene of 
interest, and a single recombinase splices together the two halves of the target DNA, 
resulting in the inactivation of the gene18. The transgenic mouse line expressing the Cre-
recombinase is guided by a promoter with a desired temporal and/or spatial pattern18. In 
rodents, aromatase enzyme expression, encoded by the Cyp19a1 gene, is restricted to the 
gonads and the brain. In the ovaries of sexually mature animals, aromatase expression is 
limited only to mural granulosa cells of healthy large antral follicles, preovulatory follicles 
and luteal cells17. Nr5a2 is expressed in the cumulus cells, whereas Cyp19a1 is not12. 
Cyp19a1 is the promoter guiding the excision of Nr5a2 in our Nr5a2Cyp19-/- model. The 
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absent expression of Cyp19a1 in cumulus cells results in unrecombined target gene, 
remaining intact and functional in the cells where the recombinase is not expressed13. 
We then performed an in vitro cumulus expansion assay to better understand the 
cumulus behavior of each mutant model. Because cumulus oophorus cells do not respond 
to LH in vitro9, we used FSH treatment to induce a regular cumulus expansion in our 
control group. Surprisingly, some degree of expansion was observed in the Nr5a2Amhr2-/-, an 
event that was not detected in vivo8. For the Nr5a2Cyp19-/- COCs, expansion was occurring 
but not in a normal degree. We conclude that the lack of Nr5a2 in mural granulosa cells of 
the Nr5a2Amhr2-/- ovaries is affecting cumulus expansion in vivo. The persistent expression 
of Nr5a2 in cumulus cells of the Nr5a2Cyp19-/- ovaries is not sufficient to promote full 
expansion, indicating that the expression of Nr5a2 in mural granulosa cells of antral 
follicles is essential for the cumulus cells to acquire the competence to expand.  
Taking into account that the two mouse models have a different pattern of cumulus 
expansion in vivo, and that both underwent a morphologically deficient expansion in vitro, 
we performed analysis to determine the cumulus expansion-related genes that are disrupted 
by depletion of Nr5a2. The EGF-like factors, Areg, Ereg and Btc are shown for the first 
time to be disrupted following deletion of Nr5a2 in granulosa cells of preantral and antral 
follicles. These genes are also disrupted in the progesterone receptor knockout (PRKO) 
mouse, which presents a phenotype of cumulus expansion without ovulation15. The 
expression of Tnaifp6, involved in the prostaglandin pathway, is also downregulated in 
both mutants. The regulation of these genes by Nr5a2 may impact the functional aspects of 
cumulus expansion that lead to ovulation.  
Before an ovulatory stimulus, i.e., an endogenous LH surge or hCG administration, 
an extensive gap junction network links the cumulus cells to one another and to the 
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developing oocyte3. Connexin 43 (Gja1) is suggested to be involved in follicle development 
and oocyte growth, and the amount of Gja1 in the large antral follicles is relatively elevated 
in a stage of high serum concentrations of FSH or eCG11. The preovulatory surge of LH 
interrupts cell-to-cell communication in the follicle, and consequently a decline in the level 
of Gja1 may suggest a specific function of Gja1 for ovulation as well as for the early luteal 
phase in processes of angiogenesis and luteal cell differentiation1. A preliminary 
unpublished (Duggavathi, 2008) electron microscopy study revealed that the mural 
granulosa cells of preovulatory follicles in Nr5a2Amhr2-/- knockout mice display an apparent 
reduction in normal cell-cell contacts. 
In our study, Gja1 expression in ovarian granulosa cells of the Nr5a2Amhr2-/- 
knockout group was downregulated at 0 h post hCG. After exposure to circulating 
ovulatory gonadotropins, the majority of the gap junctions are endocytosed, the oocyte 
resumes meiosis, and components of the extracellular matrix are deposited between the 
cumulus cells5, resulting in cumulus expansion. At 8 h post hCG, Gja1 was shown to 
remain upregulated in granulosa cells of Nr5a2Amhr2-/-, which could be an effect of impaired 
post-translational modification. The LH-induced reinitiation of meiosis involves the 
breakdown of communication between the oocyte and the somatic-cell compartment7, and 
the high levels of Gja1 by the time of ovulation found in our study may be an explanation 
for the lack of cumulus expansion in the Nr5a2Amhr2-/- mice. 
Cumulus cells create a microenvironment conducive to oocyte growth and 
development and that is necessary for ovulation and fertilization3. Successful fertilization is 
correlated with the quantity and the quality of the expanded cumulus mass. Optimal 
expansion of the cumulus mass appears to be essential for oocyte cytoplasmic maturation4. 
Interestingly, although granulosa and cumulus cells present a deficient morphological and 
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functional pattern in your Nr5a2Amhr2-/- and Nr5a2Cyp19-/- mice, the oocytes were fertilizable 
for both mutant models. Another indication that the oocytes are not involved in the 
infertility phenotype of these females is that co-culture of WT oocytes with the mutant 
COCs was unable to rescue cumulus expansion.  
We conclude that Nr5a2 regulates cumulus expansion in a temporal and spatial 
manner in ovarian follicles, and that the disruption of this gene in granulosa cells does not 
affect the fertilizability of the germ cells. 
3.6. Supplemental material   
TABLE III : List of primers used in these studies for both genotyping and qPCR. 
All primers are 5’ to 3’. 
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4. Discussion 
 Infertility in humans is a major health issue, with significant medical, physiological 
and economic aspects. According to the World Health Organization (WHO), infertility is 
defined as a failure to achieve a clinical pregnancy after 1 year or more of regular 
unprotected sexual intercourse by women of reproductive age134. Female factor is the main 
source of infertility, accounting for at least 37% of the cases in which a couple does not 
succeed in procreating. Among the causes of female infertility, ovulatory disorders lead the 
ranking (25% of the cases) while the most common female factors are endometriosis 
(15%), pelvic adhesions (12%), tubal abnormalities (22%) and hyperprolactinemia (7%)125.  
In 2010, demographic and reproductive surveys available worldwide estimated the 
infertility prevalence and trends from 1990 and 2010. Interestingly, despite the medical 
advances that are ever improving, infertility rates have hardly changed over the past 20 
years72. It was in 2008 when the nuclear receptor Nr5a2 has become known as the key 
regulator of ovulation and female fertility25. Our investigation is part of a basic research 
project toward increasing fundamental knowledge about the role of Nr5a2 in the ovary, 
aiming to provide the basis for understanding the female infertility associated with the 
ovulatory process. 
Nr5a2 was first described in the Drosophila (named Ftz-F1)116, next related to the 
mouse (Lrh-1)117 and human livers (hB1F)68, and also shown to be involved in the 
regulation of a fetoprotein (FTF)36. In Chapter 1 of this thesis, the basis of different 
nomenclature for the nuclear receptor Nr5a2 was chronicled and shown to be due to its 
multifunctional distribution in the organisms of different species. Further, it is classified as 
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an orphan nuclear receptor and the unifying nomenclature, officially naming it Nr5a2, 
occurred 10 years after its discovery23. 
The truth is that in combination with these factors implicated in the plethora of 
names, the access to public information was more restricted in the 90’s45. The integrative 
computer and web-based compiling of data became an essential tool for scientific 
communication. One well-known available scientific data bank is the National Center for 
Biotechnology Information (NCBI), launching the digital archive PubMed Central in 2001, 
providing access to biomedical and genomic information to accelerate the exchange of 
knowledge. By adopting the official gene name Nr5a2 in this thesis, we supported the idea 
of unifying the nomenclature to make this information approachable for other research 
outside as well as within the field.  
The motivation for studying the role of Nr5a2, in most of the cases, was a 
consequence of the available knowledge for its homolog nuclear receptor, Nr5a1. In 1997, 
Nr5a1 was already known to be a key determinant of the endocrine function, supported by 
in vivo data89. Indeed, Nr5a2 was commonly expected to be important in the steroidogenic-
related events in which Nr5a1 was absent or inactive. These hypotheses were true for the 
role of Nr5a2 in the breast adipose tissue in regulating aromatase22, and for its role in 
regulating gonadal steroidogenesis91, for instance. Nr5a2 deficiency in the ovary is not 
compensated by the expression of Nr5a1, ensuring the key function of Nr5a2 in ovulation 
and ovarian steroidogenesis25. 
In general, in vitro studies are a conventional system to originate new insights in 
experimental biology. They permit a detailed and convenient analysis, substantially faster 
and with fewer ethical concerns than the in vivo studies. In vitro experiments are regularly 
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chosen as the first step for unexplored fields. However, the in vivo verification is necessary 
to confirm the translation of the in vitro data. For Nr5a2, in vitro data showed the 
importance of its transcriptional regulation of Cyp7a1 in bile acid biosynthesis30. Even 
more, Cyp7a promoter-binding factor is one of the first names given to Nr5a283. 
Surprisingly, by the use of targeted somatic mutagenesis, in vivo data showed that Nr5a2 
might not be important or plays a minor role for Cyp7a1 expression73. Another example of 
a discrepancy between the in vitro and in vivo data is the regulation of LHβ and FSHβ 
transcription by Nr5a2 in gonadotrope-like cells in vitro. In this matter, Nr5a2 was recently 
shown to be dispensable for gonadotropin synthesis and fertility in vivo35.  
Supporting the importance of an in vivo extrapolation of the in vitro acquired 
knowledge, we employed our Nr5a2Cyp19-/- mouse model to study the role of Nr5a2 in 
luteinization. It was previously shown that Nr5a2 enhances the activity of Star, Cyp11a1, 
Cyp17a1, Hsd3β107, Scarb1104 and Cyp19a175 in vitro. Our data, as shown in the Chapter 2, 
corroborate the in vitro information and demonstrate that the nuclear receptor Nr5a2 is 
essential for the formation of a morphologically and functionally normal corpus luteum.  
The transgenic mouse model used in our study takes advantage of the well-
established Cre-loxP system. This system overcomes the problem encountered in the 
transgenic null-mice when the gene in evidence is important for development, causing 
embryonic lethality, well known to occur following germline deletion of Nr5a288. Through 
insertion of loxP sites into a gene of interest and by targeting the Cre-recombinase 
expression to a specific cell type using a tissue-specific promoter, it is possible to delete a 
specific portion of DNA in a specific location, such as a tissue or a cell type62. The 
transgenic  mouse  line  expressing  the Cre-recombinase  is  guided  by  a  promoter  with a  
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desired temporal and/or spatial pattern111. After intercrossing to produce double transgenic 
offspring, the recombinase may delete or modify the conditional allele in expressing cells, 
while the unrecombined target gene remains intact and functional in the cells of other 
tissues where the recombinase is not expressed50. In our studies, we took advantage of the 
unrecombined target gene, by the absence of the Cre-recombinase verified by genotyping, 
to compose our control group.  
Our two granulosa-specific knockout models presented a short window of 
difference between those carrying the Amhr2-Cre (expressed in granulosa cells of primary 
and growing ovarian follicles)28 and the Cyp19-Cre (limited only to mural granulosa cells 
of healthy large antral follicles, preovulatory follicles and luteal cells)110. Our data provides 
the first insight into the role of Nr5a2 in the ovarian function in a time line manner. We 
compared the Nr5a2Amhr2-/- model, which had already been previously described and was 
used as the basis of our study, with the Nr5a2Cyp19-/- model, described herein for the first 
time, presenting an interesting and particular reproductive profile.  
These two models are consistent in their lack of ovulation and the competence of 
the oocytes to be fertilized, but they differ regarding the formation of the luteal-like 
structures and their ability to undergo cumulus expansion. The studies were conducted in 
parallel, with both mutant models treated and analyzed in the same conditions, allowing for 
the comparisons between them. The role of Nr5a2 in cumulus expansion, explored in the 
Chapter 3, although substantially advanced herein, is not yet fully understood. It would be 
of interest to perform a next-generation transcriptome sequencing of the ovarian granulosa 
and cumulus cells to better clarify the regulation of Nr5a2 in cumulus expansion.  
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Together, our data provide new information on how Nr5a2 regulates peri- and post-
ovulatory events in the mouse ovary. It complements the current array of basic research, 
and provides fundamental insight that may be useful towards an application for Nr5a2, for 
instance, on the rescue of female fertility or on the possibility of a contraceptive 
development52. To this end, it is important that different areas of research move forward 
together. The new discoveries on synthetic ligands regulating Nr5a2 benefit the 
investigations on its biological functions, and provide an opportunity for the treatment of 
infertility, cancer and metabolic disorders in which Nr5a2 might be involved61.  
The mouse constitutes an important animal model to study reproduction and other 
processes due to its anatomy, physiology and genetic presenting similarity to humans11. 
Using mouse in this kind of research has advantages like relatively short generation time, 
post-partum estrus and ability to manipulate its genome50. However, significant interspecies 
differences in gene regulation might exist when comparing mice data to human 
physiology30. Ideally, human ovarian cells should be investigated comparing women with 
ovulatory disruption with fertile women. Going even further, Nr5a2 is known to be 
expressed in ovarian cells of most animals as well, so it would be not only important in 
human fertility, but also in veterinary research. 
In the case of human infertility, our mouse data raise a hope. We show, for the very 
first time, that the oocytes resulting from follicles lacking Nr5a2 in the somatic cells are 
fertilizable. Assisted reproductive technology (ART) includes fertility treatment for humans 
in which both female germ cell and male germ cell are manipulated in vitro. The resulting 
embryo is transferred to the woman’s uterus for the progress of the pregnancy. The in vitro 
fertilization (IVF) and the intracytoplasmic sperm injection (ICSI) are widely used as 
ARTs. In IVF, the sperm and the egg are incubated together, and the sperm will penetrate 
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the egg by itself. In the ICSI, one single sperm is artificially introduced directly inside the 
oocyte.  
If it is shown that the disruption of Nr5a2 in women granulosa cells is related to 
ovulatory disorders in humans, our mice data would suggest that the ART would be able to 
overcome the lack of ovulation and embryonic conception. It is important to mention that a 
pregnancy is dependent on a functional corpus luteum secreting progesterone, and the 
uterine factors are also essential.  Our laboratory has recently shown that uterine functions 
are regulated by the expression of Nr5a2, mediating embryo implantation and 
decidualization135. Another recent study showed that the infertility caused by the depletion 
of Nr5a2 is reversible in the mouse37. Therefore, it would be of great value to apply and 
combine the available information to establish the relation between Nr5a2 and human 
infertility. 
With the present study, we hope that the infertility statistics can change. Nr5a2 is a 
potential target for fertility dysfunctions and contraception. It is possible that, in the next 
decades, the studies on the fertility rates worldwide will show an improvement in female 
fertility, and this thesis will have contributed to the field as a fundamental portion of the 
puzzle. 
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Conclusion 
In conclusion, our study permits an increase in understanding the role of Nr5a2 in 
female reproduction, with a focus on new information relative to ovarian peri- and post-
ovulatory events. Our findings demonstrate that Nr5a2 regulates essential mechanisms of 
female fertility in granulosa cells during the process of follicular development, in a spatial 
and temporal manner. We have determined that the lack of functional Nr5a2 in ovarian 
granulosa cells of antral follicles results in development of non-functional luteal-like 
structures in the absence of ovulation. We elucidated the morphological and functional 
process of cumulus expansion regulated by Nr5a2 in preantral and antral follicles. Our data 
demonstrating the competence of the oocytes have shown that the disruption of Nr5a2 in 
somatic cells of the follicle does not affect the capacity of the germ cells to be fertilized. In 
summary, this study has provided new insight into the role of the nuclear receptor Nr5a2 in 
the ovarian regulation and allowed us to achieve our specific objectives. Moreover, new 
questions arise, such as: What would be the ovarian phenotype of female mice 
overexpressing Nr5a2 in granulosa cells? What is the relation between our mouse data and 
the human ovulatory dysfunctions? Is Nr5a2 involved in the regulation of female ovarian 
cancer or polycystic ovarian syndrome? This remains a fertile field for investigation of 
nuclear receptor regulation of ovarian functions. 
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5.1.1. Summary 
The laboratory mouse is an essential model for investigation of normal mammalian 
physiology, dysfunction and disease. Under conditions of long photoperiod, mice breed 
continuously throughout the year. In unbred mice, the estrous cycle is a continuum of 
approximately four days in length, characterized by hormonal variation and consequent 
morphological and physiological changes to the reproductive tract. Four stages of varying 
duration are recognized. Proestrus is the period during which pre- and peri-ovulatory 
development take place in the ovary, with consequent synthesis and secretion of estrogens. 
Estrus, the brief interval during which the female accepts the male and during which 
ovulation occurs, follows. Next is metestrus, the early luteal phase, followed by diestrus, 
during which progesterone is the dominant hormonal influence. Two cell types, 
polymorphonuclear leukocytes and squamous epithelial cells predominate in the exfoliative 
cytology of mouse vagina. Stages of the estrous cycle can be identified from the 
assemblage of these cells. In this chapter, the continuum of morphological changes in the 
reproductive tract and in vaginal cytology are documented to provide tools for reproductive 
management of a mouse colony.  
 
Key words: estrous cycle, mouse, smears, vagina, ovaries, uterus 
 
 iv 
5.1.2. Introduction 
The laboratory mouse (order Rodentia, family Muridae, genus Mus, species 
musculus) has a long history of use as a model for the investigation of reproductive events, 
for a number of reasons beyond its small size and inherent fecundity. Mice are polyestrual 
mammals, they spontaneously ovulate and the intervals between parturitions are short, 
requiring approximately 21 days. A further particularity in the mouse that render this 
species propitious for the studies in reproduction is the short length of its estrous cycle, 
which lasts only 4 to 5 days. The mouse estrous cycle is an iterative event manifested in 
changes in the anatomy, endocrinology, physiology and behavior, all coordinated to 
provide the maximum fecundity. 
The synchrony of the hypothalamus-pituitary-gonadal axis is crucial for the rhythm 
of the cycle and for the success in reproduction. While the estrous cycle is continuous, 
discrete phases can be identified, proestrus, estrus, metestrus and diestrus. Specific 
hormones drive the changes that occur during each phase of the cycle and induce the 
transformations in the mouse anatomy. These variations render identification of individual 
phase possible by examination of the vaginal appearance and of exfoliated vaginal cells. 
The pioneer studies that revealed the elements of the mouse estrous cycle were published 
approximately 100 years ago, signaling the initial steps in a research journey that has 
allowed achievement of the current extensive understanding of animal reproduction.  
The dynamic nature of this complex of cyclic physiological changes continues to 
intrigue researchers. Advancements, combining modern technology with traditional studies, 
have allowed the establishment of mouse strains that predictably develop cancers, obesity, 
neural dysfunction and other disorders. These models have been highly useful in 
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establishing the bases for human and animal disease. In addition, the mouse has been a 
robust model for transgenic investigation. Microinjection technology has been used to 
insert transgenes, and the development of homologous recombination in embryonic stem 
cells allowed for the production of chimeric mice. These methods permit the null mutation, 
overexpression and tissue and cell type targeted modifications of the mouse genome, 
providing powerful tools for the exploration of gene function in whole animal models. 
Immunodeficient mice, of which there are several strains, have served another important 
experimental purpose, as recipients of xenografts to explore development of cells and 
tissues, as recipients of embryos, and for development of pharmacological approaches to 
address disease states. Technology to exploit the mouse as an experimental model is 
evolving rapidly, with new approaches, such as incorporation of transgenes into 
spermatogonial stem cells28, then transplanted to the testis, use of viral vectors to insert 
mutated sequences and use of specifically designed nucleases to transmit transgenes33.   
The enormous contribution that the mouse has made to understanding of mammalian 
biology required the establishment of accurate and reliable criteria for evaluating 
reproductive function. The purpose of this chapter is to illustrate the reproductive 
phenomena of the estrous cycle of the normal or wild type mouse as a guide, not only to 
successful propagation of mouse colonies, but also to investigation of the fascinating story 
of mammalian reproduction. Decades of mouse breeding in numerous laboratories and 
institutes have resulted in multiple strains of mice, with the consequence of some variation 
in reproductive events. In this chapter we will focus on a general view of the mouse estrous 
cycle, rather than focus on individual peculiarities or comparisons between different strains. 
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5.1.3. Female mouse reproductive tract anatomy 
5.1.3.1. Macroanatomy  
The laboratory mouse, as a murine rodent, displays the typical bilateral reproductive 
morphology that characterizes mammalian vertebrates. The ovaries are found in a subrenal 
fat pad and the bicornuate uterus (Figure 5.1, bottom panels) is confluent with the external 
vaginal opening (Figure 5.1, top panels). The ovarian blood supply originates from the 
ovarian arteries that branch from the descending aorta. The uterus is supplied by the uterine 
branch of the ovarian artery. 
 
 
Figure 5.1 : The macroanatomic manifestations of the estrous cycle in a C57BL/6-129 mouse line, 
including external (top panels) and internal changes (bottom panels) in the reproductive tract. A-D) Changes 
in the vaginal opening along the cycle, underlining the vulva swelling with the lip demarcated by dotted lines. 
E-H) Internal reproductive tract in mice with the uterine horns outlined by a dotted line; letters identify the 
ovary (O); uterine horn (U); cervix (C). Scale bars calibrate to 2 mm. 
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The anterior end of the mouse oviduct forms a bursa that encapsulates the ovary, 
ensuring that the products of ovulation are directed toward the uterus. The oviduct itself is a 
coil of approximately 11 turns that, when uncoiled approximates 1.8 cm in length. It has 
three anatomic subdivisions, the infundibulum, a component of the bursa that receives the 
oocytes, the ampulla where fertilization takes place, and the isthmus that connects to the 
uterus via the utero-tubal junction (Figure 5.2, top panels).     
 
 
Figure 5.2 : The uterine macroscopy and microscopy during the estrous cycle. A-D) Dissected female 
internal reproductive tract, where O indicates the ovary, OV the oviduct, demarcated by dotted lines; U 
indicates the uterus and C the uterine cervix. Scale bars calibrate to 2 mm. E-H). Bright field microscopy 
images of hematoxylin-eosin stained sections of the uterus representing the histological changes in the uterine 
layers during the estrous cycle in the mouse. P indicates the perimetrium; M, myometrium; E, endometrium; 
L, lumen; Ep, endometrial epithelium; St, stromal compartment; Ug, uterine glands. Scale bars calibrate to 0.1 
mm. 
 
The oviduct and the uterine horns are both derived from the Müllerian ducts, and thus 
comprise a continuous tubular structure with mucosal, muscular and adventitial layers and 
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extending to the uterine cervix (Figure 5.2, bottom panels). All are sensitive to the local and 
systemic hormonal milieu, and undergo substantial changes during the adult mouse estrous 
cycle.  
The cervix is the opening to the uterus, and it is continuous with the vagina, which 
maintains the trilaminar structure of the inner mucosa, smooth muscle layers and outer 
adventitia. In the adult mouse, the vaginal mucosa is lined by stratified squamous 
epithelium. As will be noted below, the epithelial and reticuloendothelial system cell 
morphology and composition undergo hormonal variations, reflecting the changes that 
occur during the estrous cycle. A single ventral and two dorsal lips characterize the vaginal 
opening and it is protected by the vulva, the female external genital organ. These regions 
likewise undergo recognizable morphological changes during the estrous cycle (Figure 5.1, 
top panels). 
5.1.3.2. The ovary, development and microanatomy 
The ovary of the mouse begins to develop at approximately day 9.5 post copulation 
(dpc). The somatic cells are derived from the embryonic mesonephros and the coelomic 
epithelium, and the primitive gonad begins to develop by dpc 10. The primordial germ cells 
that will give rise to the oocytes, differentiate at the base of the allantois about dpc 7.5 and 
migrate to the genital ridge at approximately 9.5 dpc29. Between 10.5 and 13.5 dpc, the 
mouse oocytes divide mitotically25, and the consensus among scientists is that, this mitotic 
event supplies all of the oocytes that will populate the adult ovary. The oogonia, grouped in 
cysts, then begin to enter meiosis and proceed to the dictyate stage of the first meiotic 
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prophase. There, further meiotic progression is arrested until the oocyte and its follicular 
somatic component are recruited to the growing follicular pool.  
Although follicle entry into the growing pool is a continuum, populations of follicles 
at different stages of the process have been defined based on morphological 
characteristics17. The primordial follicles appear 1 to 2 days after birth, when flat squamous 
pre-granulosa cells surround oocytes. Those with a single layer of cells that have 
transformed from squamous to cuboidal cells are seen first at postnatal day 3, and are 
designated primary follicles, while those with two or more layers but no antrum are known 
as secondary follicles. At day 7, primordial follicles are the most abundant follicular type, 
but primary and secondary follicles, having more than 1 layer of granulosa cells and an 
additional theca layer, are present in the medullar region. The first antral follicles in the 
mouse are present by day 13 following birth. By day 21, multiple layers of granulosa cells 
that contain scattered areas of interstitial fluid surround the oocyte21. Preovulatory follicles 
are identified by their defined cumulus oophorus, a multilayered investment of the oocyte 
with a subtype of the granulosa cells that is distinct from the mural population (Figure 5.3). 
First ovulations are seen in mice between 30 and 40 days of age. 
The ovary of the adult mouse undergoing estrous cycles (Figure 5.3) is covered with 
epithelium of peritoneal origin. The point of entry and exit of the vasculature is the ovarian 
hilus, which defines the center or cortex of the ovary. The majority of the follicles is in the 
primordial state and located at the periphery of the medulla. Enumeration indicates that 
there are approximately 8000 of these present at birth in the C57BL/6 mouse, declining to 
about 2500 by day 7 after birth, mostly due to oocyte demise13. Once a follicle transits from 
the primordial population, it is committed to the growing pool to either ovulate (a small 
percentage) or become atretic (the majority). It has been estimated that 3-6 mouse follicles 
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enter the growing pool daily3. It requires approximately 16 days for the healthy follicles to 
reach the preovulatory stage20. Most atresia happens on follicles in the pre-antral and early 
antral state10.   
 
 
Figure 5.3 : Bright field microscopy images of hematoxylin-eosin stained sections of entire ovaries 
depicting the assemblage of structures present during the estrous cycle of the mouse. SE, surface epithelium; 
O, oocyte; CL, corpus luteum; AF, antral follicle; CC, cumulus cells; H, hilus; PAF, preantral follicle; TC, 
theca cells; GC, granulosa cells. Scale bars calibrate to 0.1 mm. 
 
The web of interaction between the oocyte, granulosa cells, theca cells, pituitary and 
hypothalamus ultimately selects follicles for ovulation23. After ovulation, the follicle 
undergoes massive reorganization. The thecal vascular elements invade, bringing thecal 
cells to mix with the remodeling granulosa population to form the corpus luteum (CL) 
(Figure 5.3). If mating has not occurred, the CL undergoes functional regression, with 
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reduction in progesterone (P4) output that allows the next cycle to take place (see hormone 
variations, below).   
5.1.3.3. Hormonal variations drive the estrous cycle 
The hypothalamus-pituitary-gonadal axis regulates all the reproductive changes along 
the estrous cycle. Gonadotropin-releasing hormone (GnRH) from the hypothalamus reaches 
the anterior pituitary, stimulating the secretion of follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH). Antral follicles are responsive to these two gonadotropic 
hormones when they reach the ovary. FSH acts primarily to promote follicular growth, 
granulosa cell proliferation, aromatization of androgens to estrogens and LH receptor 
expression. LH is also necessary for follicle growth, particularly at the late stages, and, as 
noted below, induces ovulation. Both gonadotropins promote the secretion of gonadal 
hormones, i.e., estrogen and progesterone, necessary for the proper execution of the follicle 
development program and responsible for maintaining the secondary sexual characteristics 
and reproductive cyclicity. The uterine and vaginal manifestations of the mouse estrous 
cycle are the product of the steroidal influences resulting from the cyclic changes in the 
ovary. The hormone profiles that accompany the ovarian cycle (Figure 5.4, a) have resulted 
from multiple studies from laboratories around the world during the last century.  
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Figure 5.4 : Depiction of hormone profiles across the mouse estrous cycles and pseudopregnancy. A) 
Diagram of the serum hormonal profile for each different stage of the cycle. FSH in orange line; LH, blue; 
Prolactin, yellow; 17β Estradiol, red; Progesterone, green. Composite information from multiple publications, 
adapted from McLean et al, 201215. B) Evidence of the male secretions forming the vaginal plug after 
copulation. C) Mating frequency of females housed with vasectomized males during 40 days of breeding trial; 
black squares mean copulation plugs, with approximate 10 day intervals between each plug, indicating 
pseudopregnancy induced by mating.    
 
During proestrus, antral follicles grow exponentially under the influence of FSH, and 
we see the last stages of development of the cohort of preovulatory follicles. A large body 
of work across numerous species of mammals has shown that this stage of follicle 
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maturation, driven first by FSH, then by LH, results in a relatively large-scale conversion of 
thecal androgens to estrogens, mostly estradiol 17ß (E2). Proestrus is characterized by 
estradiol affecting the hypothalamus in a positive feedback manner, therefore when E2 
increases, LH peaks, still during proestrus (Figure 5.4, a)6. 
Ovulation in the mouse follicle occurs approximately 12 to 14 hours after a surge of 
LH coinciding with the estrus phase, and coincident with the period during which the 
female will allow mating. Ovulation, due to the remodeling of the preovulatory ovarian 
follicles into corpora lutea, engenders the shift from the estrogen to progesterone as the 
principal secretory product. This takes place during metestrus and diestrus, the luteal phase 
of the mouse cycle. Beyond the positive feedback induction of the LH surge, the acute 
elevation of estrogens has multiple consequences. These include the generation of protein 
synthesis, uterine fluid accumulation, uterine elongation and cornification of the vaginal 
epithelium. Local concentrations of progesterone and estrogen, derived from circulation, 
alter the morphology of the endometrial component of the mouse uterus (Figure 5.2).  
During metestrus and diestrus, progesterone inhibits the secretion of LH and 
consequently, prevents further ovulation. The functional demise of the corpus luteum 
toward the end of metestrus results in reduction in progesterone synthesis due to its 
conversion to the less potent progestogen, 20α-OH-progesterone. The decline in 
progesterone releases inhibition of LH secretion, allowing proestrus to ensue. Thus, in the 
unbred mouse the functional regression of the corpus luteum occurs during late diestrus.   
Structurally, the CL in the unmated mouse persists for two to four cycles4 after 
functional regression, and multiple generations of these structures can be present in the 
ovary at any time during the cycle. This renders in vivo studies of ovulation and early CL 
development difficult. The model of choice for exploration of this genre has been the 
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immature mouse, where follicle development is hormonally induced prior to the first 
ovulation. The protocol for hormonal synchronization in mice is based on the injection of 
equine chorionic gonadotropin (eCG), a hormone that mimics the FSH effect, followed by 
an injection of human chorionic gonadotropin (hCG), which has LH-like activity, 44 to 48 
hours after eCG. Ovarian responsiveness to the hormonal superstimulation in the immature 
mouse takes place around 22 to 25 days of age. In this superstimulation model, all CL 
produced are products of the current ovulation.  
Mating in the mouse is normally detected by the occurrence of vaginal plugs (Figure 
5.4, b), formed by a mixture of the secretions of the vesicular and coagulating glands of the 
male, that usually fills the vagina from cervix to vulva4. Vaginal plugs are most likely to be 
seen in the morning after the copulation event, and it can persist from 16 to 48 hours. 
Mating induces the formation of a more persistent corpus luteum, that of pregnancy. The 
mechanism has been best studied in the rat11 and comprises a neuroendocrine loop whereby 
mating induces a diurnal and a nocturnal surge of prolactin secretion from the pituitary, in a 
pattern that persists for 8 to 10 days2. Prolactin inhibits expression of 20α-hydroxysteroid 
dehydrogenase, thereby preventing conversion of progesterone to 20α-OH-progesterone34. 
Mating of the mouse to a vasectomized male results in persistence of a functional corpus 
luteum for approximately 10 days (Figure 5.4, c)16. The evolutionary utility of this system 
is evident, it abbreviates the return to estrus in the unbred mouse, increasing reproductive 
potential during the breeding season. 
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5.1.4. The mouse estrous cycle 
5.1.4.1. General considerations 
In some respects, repetitive estrous cycles in the mouse may be considered a 
condition induced by human intervention and captive breeding as Mus musculus is an 
efficient breeder in nature. The brief estrous cycle and postpartum estrus ensure that the 
female is in gestation at any given moment during the breeding season. Under natural 
conditions, the breeding season for this species includes summer and autumn22 and 
photoperiod is the major environmental regulator. The strategy used in captivity to maintain 
mice breeding throughout the year in the laboratory colonies is based in the duration of the 
artificial light:dark cycle. Mice are under the light condition for 14 hours and under the 
dark for 10 hours per day, imitating the length of a summer day and night.  
The estrous cycle in the laboratory mouse is most commonly of four days duration, 
but can be as long as six days, and can vary between strains of mice. The attempts to 
determine the length of the mouse estrous cycle required several years of investigation. 
Early work proposed that the cycle lasted approximately 20 days, substantiating the 
observations at the immediate post-partum estrus. Around the year 1888, using sterile 
mating, the interval between two copulations was considered the length of the cycle, 
leading the authors to place the length to 10 days. We now know that mating, even though 
sterile, results in the formation of a functional CL, as discussed above in the hormone 
variations section, inhibiting the occurrence of estrus for approximately 10 days. It was 
only in 1922 that the peak of frequency curve for length of cycle was discovered to be 4 to 
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5 days1; 19. This was possible because of the evaluation of vaginal cells to determine each 
phase of the cycle, avoiding the formation on the inducible CL by mating.  
A fertile postpartum estrus results in simultaneous lactation and gestation, whereas 
the interval between parturition and ovulation is about 14 to 28 hours. Fertility at this 
postpartum mating is less efficient4. After this immediate postpartum period, no further 
estrus is observed until the end of the normal lactation period, which lasts about 19 to 21 
days.  
The length of each stage of the cycle may vary as well, but an average can be 
determined as: early proestrus, 11 hours; late proestrus, 21.4 hours; estrus, 20.7 hours; 
metestrus, 21.8 hours; and diestrus, 21.8 hours; for a total of 4.3 days30. The onset of estrus, 
determined by willingness to mate, usually occurs between 2200 and 0100 on the day of 
proestrus. Ovulation takes place between 2330 and 0430 and it is spontaneous, i.e., 
independent of the copulation. The interval between the onset of estrus and ovulation is 
variable, but it is estimated to be 2 to 3 hours26. There are a number of factors that can alter 
the length of the cycle, including the presence of a male, the number of females in the same 
group, the time of exposure to the light:dark system, and, of course, administration of 
exogenous hormones. Mice are sensitive to the olfactory-mediated stimuli, in the form of 
the pheromones released from both males and females. Olfactory stimuli originate from the 
presence of a male can induce estrus, accelerate the cycle, and regularize abnormal cycles. 
This effect can be mimicked by exposing female mice to urine from male mice, and this 
results in alteration of the expected pattern of estrous synchrony14.  
Mice are also responsive to neurotropic stimuli, including social stress associated 
with behavioral competition provoked by crowding which causes abnormal cycles found 
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under crowded conditions31. Crowding is known to alter some aspects of central nervous 
system activity and increase the synthesis and release of adrenocorticotropic hormone 
(ACTH), what may alter ovarian function9, suppressing or inhibiting the estrous cycle. It is 
shown that housing large group of females (20 females/cage) resulted in prolonged vaginal 
diestrus, followed by evidence of ovulation at 10 to 12 day intervals, leading to the 
conclusion that housing female mice in large groups induces a luteotropic formation 
causing pseudopregnancy rather than anestrus24. 
The environment illumination also plays a role in the regulation of the estrous cycle. 
Continuous lighting prompts dramatic alterations in the cycle, comprising continuous 
vaginal cornification, cystic follicles in the ovary and the absence of ovulation, lengthening 
the cycle7. Reversing the daily rhythm of light and darkness reverses the time of estrus, 
ovulation and copulation.  
The estrous cyclicity is also related to the age of the females. From puberty, which 
happens at 5 to 6 weeks of age, cycle frequency and length is initially low, due to 
prolonged cycles and late-starting cyclers. The peak of cycle frequency and length starts 
from 3 to 5 months of age, and it lasts until females are 7 to 10 months old. With aging, the 
frequency and the length of the cycle decline, and the age for the cessation of the cyclicity 
can be up to 16 months18. The average age for the onset of acyclicity starts from 11 months 
of age, and it is characterized by the persistent vaginal cornification, which is defined by an 
absence of CL, presence of poly-follicular ovaries that continue to secrete estrogens12. 
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5.1.4.2. Changes in the reproductive tract 
The estrous cycle is characterized by multiple remodeling events it the ovary in 
support of ovulation and gestation. As noted above, it has been divided into four stages of 
unequal length based on the events that occur in the ovary and their consequences on other 
reproductive tissues (Figure 5.1) and reproductive behavior. Figure 5.3 depicts the changes 
in ovarian landscape over the estrous cycle. In proestrus, the dominant structures are the 
antral follicles that are developing to the preovulatory state. Estrus is characterized by the 
final stages of development of the preovulatory follicles and ovulation. If the cycle is not 
interrupted by pregnancy, pseudopregnancy, or other phenomena, metestrus will begin. At 
metestrus, the new corpora lutea can be seen in the ovary. Diestrus, corresponding to the 
luteal phase, extends for two of a four day cycle during which prominent corpora lutea are 
present in the ovary (Figure 5.3). 
The uterus also undergoes morphological variation across the estrous cycle in 
response to the steroidal environment engendered by the preovulatory and luteal events. 
The transformations seen in the uterus include histological changes in the luminal and 
glandular epithelium, in the stromal cells, in the secretory activity of the uterine glands and 
in the distention and shape of the uterine lumen (Figure 5.2). Total uterine thickness 
directly correlates with E2 levels, and inversely with P4. Luteal progesterone levels are 
correlated with uterine width, reduced luminal epithelial proliferation and decreased 
stromal apoptosis. The elevated estrogen levels of proestrus are associated to greater uterine 
width, more stromal cell proliferation, decreasing the glandular epithelial proliferation, and 
a reduced frequency of luminal, glandular and stromal apoptosis. E2 levels have been 
implicated in protection of glandular endometrial cells from apoptosis32.  
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The uterus during proestrus and estrus is thick and edematous, and the distention 
appearance is due to the hyperfunction of the uterine glands, once the maximum secretory 
activity occurs at estrus, as the stromal proliferation is greatest associated with elevated 
level of E2 (Figure 5.2, a). At proestrus, a typical undulating endometrium with projections 
of endometrial tissue into the lumen is present (Figure 5.2, e); at estrus, the extracellular 
fluid throughout the endometrium is increased (Figure 5.2, b and f)32. Edema begins to 
diminish in late estrus, evidently declining during metestrus (Figure 5.2, c), and the stromal 
apoptosis is highest at this point, correlated with the relatively low levels of E2 and P4. 
During metestrus, a degenerative process takes place, and the epithelium loses its definitive 
organization, shows vacuolar degeneration, leukocytes appear in the basement membrane, 
and uterine glands show minimum activity (Figure 5.2, g). The turnover to a regenerative 
process determines the onset of diestrus4. At diestrus, uterus is thin and elongated (Figure 
5.2, d), and the uterine wall is collapsed and anemic (Figure 5.2, h). During diestrus and 
proestrus, mitoses are frequent in the glands, becoming fewer in number as functional 
activity increases1.  
The hormonal milieu, especially predominately estrogen, will dictate the cell 
typology within the murine vaginal smears, reflecting changes in the vaginal epithelium 
(see estrous cycle determination, below). The cells found in the vaginal smears are 
basically leukocytes, cornified epithelial cells and nucleated epithelial cells. The changes in 
the vaginal epithelium comprise modifications in the number of layers in the epithelium, 
the amount of cornification and the changes from live to dead cells, the presence of surface 
mucus and the presence or absence of polymorphonuclear leukocytes. Proestrus and estrus 
are determined by the proliferation in the genital tract, culminating in ovulation, mating and 
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fertilization. Metestrus is characterized by degeneration in the reproductive tract, whereas 
diestrus is a period of quiescence or slow growth4.  
At proestrus, the vaginal epithelium consists of three layers, including the stratum 
germinativum, the stratum granulosum, and a layer composed of epithelial cells with nuclei 
showing signs of pyknosis4. In this stage, there is maximal opening of the vagina, 
accompanied by swollen labia and a moist external orifice, there are often wrinkles and 
striations along the dorsal and ventral edges (Figure 5.1, a)5, and the fluid on its lumen is 
serous. During proestrus and early estrus, cells of the outer layer of the vagina are sloughed, 
producing the aspect of nucleated cell smear. Cells are sloughed from the cornified layer 
during late proestrus and throughout estrus4. In estrus, vulva may still be swollen, but the 
vagina appears less open, the tissues are less moist and less pink (Figure 5.1, b).  
Metestrus is the stage when vulva has usually lost most of its swelling, the orifice of 
the vagina is tightly or partly closed and the lumen is less moist (Figure 5.1, c). The vaginal 
content changes from a pasty or viscous to a fluid consistency. It is characterized by the 
peeling off of the entire stratum, and the delamination process includes some of the 
superficial layers of the stratum germinativum. As diestrus ensues, the vulva becomes 
inconspicuous and the vaginal gap is tightly closed, containing a viscous and stringy fluid, 
with no tissue swelling (Figure 5.1, d)6. The vaginal epithelium in this stage contains only 
the stratum germinativum, which actively grows late in diestrus; by proestrus, the stratum 
granulosum has formed several cell layers below the surface, thereby completing the cycle4.  
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5.1.4.3. Determining the estrous phase 
Methods for determination of the stage of the estrous cycle are essential to mouse 
breeding programs, for determination of reproductive phenotypes and for investigation of 
reproductive landmarks such as puberty and age related depletion of the follicle reserve. 
The exterior aspect of the vagina has been successfully employed to approximate the stages 
of the cycle8 (Figure 5.1, top panels). The openness of the vagina, the relative tumescence 
of the external genitalia and tissue coloration (in albino mice)5 provide indicators of the 
stage of the ovarian cycle, as described above. Beyond the visual observation of the 
external genitalia, the changes in the mouse estrous cycle can be determined using methods 
such as electrical impedance and biochemical analysis of the urine5.  
As the ovarian and hormonal changes evoke major modification in the vaginal 
epithelium, the most frequently applied and reliable method for estrous cycle determination 
in mice is the evaluation of the vaginal cytology. The guinea pig was the species where 
cytology of exfoliated tissues in the vagina was first used to establish the estrous cycle, 
published nearly 100 years ago by Stockard and Papanicolaou27. Vaginal smears can be 
read with or without staining, but latter is somewhat more difficult, particularly to the 
inexperienced eye (for more details, see Monitoring mouse estrous cycle, the protocol). 
The identification of the estrous stage is based on the proportion of two cell types 
observed in the vaginal smear, the epithelial cells derived from the stratified squamous 
epithelium that lines the vagina and polymorphonuclear leukocytes, primarily neutrophils6. 
Figure 5.5 depicts the cellular assemblages that characterize the temporal changes during 
the cycle.  
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Figure 5.5 : Assemblages of cells exfoliated from the mouse vaginal epithelium across the estrous 
cycle of the laboratory mouse showing the cellular assemblages that define the days of the cycle and the 
transitions between stages of the cycle. P signifies proestrus; P-E, the transition between proestrus and estrus; 
E signifies estrus; E-M, the transition between estrus and metestrus; M, metestrus; M-D, the transition 
between metestrus and diestrus; and D, diestrus. Vaginal smears were collected by infusing and removing ≈10 
µl of PBS 1X, smears were dried and stained with May-Grünwald Giemsa. 
 
Proestrus is characterized by squamous epithelial cells with visible nuclei seen in 
clusters or individually; very few lymphocytes and polymorphonuclear cells are observed 
in this phase (Figure 5.5, P). Following proestrus, the estrus assemblage contains squamous 
epithelial cells gradually becoming more cornified (Figure 5.5, P-E), with no visible nuclei, 
granular cytoplasm and irregular shape (Figure 5.5, E). At the end of estrus, there is a mix 
of cell types including leukocytes and cornified epithelial cells aggregating into cluster 
formations (Figure 5.5, E-M). By metestrus, the exfoliated cell population is dominated by 
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leukocyte infiltration and cuboidal epithelial cells are present (Figure 5.5, M). As the cycle 
progresses, neutrophils are found in combination with the cuboidal like epithelial cells 
during the transition to diestrus (Figure 5.5, M-D). Diestrus consists predominately of 
leukocytes no longer in association with the epithelial cells, that are non-nucleated and in 
fusiform shape indicating cell death (Figure 5.5, D). During transition to proestrus, 
neutrophils decline and epithelial cells with obvious nuclei are the principal cell type found 
(Figure 5.5, D-P). Anestrus is characterized by non-cornified epithelial cells and by the 
absence of proestrus/estrus for a long period. It must be emphasized that, in the unbred 
mouse, the cycle is a continuum, thus transition phases have been included in the composite 
photomicrograph. 
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5.2.1. Introduction 
Managing a mouse colony requires careful observation at both macroscopic and 
microscopic levels to determine the phases of the estrous cycle. There are several situations 
that challenge the researcher, for instance, choosing the best females for a breeding 
program, to define the reproductive phenotype of a transgenic mouse line or to characterize 
events related to the different stages of the estrous cycle. The physiological changes that 
occur during the estrous cycle are manifest in changes in both the macro and microanatomy 
of the mouse reproductive system. An approximate determination of the estrous phase can 
be performed by visual observation of the external vagina (Figure 5.1 in section 5.1). This 
method is rapid, requires no special equipment, and permits numerous evaluations to be 
done without requiring sampling of the vaginal tissues. However, it can be inconclusive 
when the animals are in metestrus or diestrus, and it is hampered by the strain of mouse, 
i.e., it is more difficult in lines with darker pelage. This method can be employed as a 
preliminary evaluation but definitive evaluation requires confirmation by vaginal cytology 
assessment.  
 Vaginal smear analysis is the preferable technique for accurately determining the 
estrous phase in mice. This technique was first described in rats, based on the correlation 
between the layers of the characteristic desquamated vaginal epithelium and the hormonal 
profile for each stage of the estrous cycle5. In mice, evaluation of these exfoliated cells that 
can be obtained by scraping, swabbing or by vaginal washings, also serves as an indicator 
of the reproductive state. Recognition of the relative ratio of vaginal cells on a particular 
day is the imperative tool for successful determination of the estrous phase:  
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•  Proestrus: the vaginal smear is characterized by the predominance of nucleated 
vaginal epithelial cells, seen in clusters or individually; very few leukocytes are present.  
•  Estrus: distinguished by the disappearance of leukocytes and the presence of 
cornified squamous epithelial cells, which are large, non-nucleated and irregular in shape. 
Early estrus may show some nucleated epithelial cells. 
•  Metestrus: there is a mix of cell types; an invasion of leukocytes occurs, and the 
non-nucleated epithelial cells are usually clustered; dying epithelial cells adopt a fusiform 
shape.  
•  Diestrus: leukocytes are predominant; non-nucleated epithelial cells are mostly 
fusiform; the vaginal contents in this phase consistently lack cornified cells.  
To be able to determine whether the female is undergoing regular cycles, vaginal 
cytology patterns should be analysed over two weeks (at least three cycles). It is important 
to observe proestrus, indicating the beginning of a new cycle, followed by estrus. The 
persistence of non-cornified epithelial cells is an indication of anestrus. The invasiveness in 
collecting the smears should be taken into consideration, since it can alter the regular 
reproductive status. The first days of handling can cause stress to the animal and may cause 
a transient disruption in the estrous cycle. Frequent smearing can also artificially induce the 
cornification of the vaginal epithelium; result in pseudopregnancy followed by abnormally 
long cycles; or moreover, can elicit an inflammatory response that can mask the cytological 
assessment. The vaginal epithelial cell cycle is a continuum (Figure 5.5 in section 5.1); 
therefore smears taken at some times may not fit perfectly into the defined categories of 
estrous phases, as they represent a transition between two phases1. 
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5.2.2. Protocol: Collecting the vaginal epithelial cells 
Materials: 
Post-pubertal female mice (approximately 40 or more days old) 
Sterile plastic pipette (Figure 5.6, a) 
Phosphate buffer saline (PBS 1X) 
Light microscope with 10x objective 
Glass slides  
 
Identify the animal by number or other mark. Place the mouse so that its front paws 
grasp the top of the cage, with its posterior end towards you, and firmly restrain the tail and 
elevate the dorsum (Figure 5.6, b). Alternatively grasp the animal by the nape of the neck to 
immobilize it. A sterile plastic pipette is gently inserted at the vaginal opening (Figure 5.6, 
c) and used to flush the vagina gently 3 to 5 times with approximately 10 µl of PBS 1X at 
room temperature; care should be taken not to insert the dropper too deep and not to flush 
too much PBS at once. Place final flush containing vaginal fluid on a properly identified 
glass slide. Use a coverslip to spread the drop. Wash the droppers between mice. If the drop 
dries, it is possible to add more saline (<10µl) with another clean pipette tip to rehydrate.  
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Figure 5.6 : Collection of vaginal smear in mice. A) Sterile plastic pipette recommended for collecting 
the cells. B) Restraint method. C) After the female mouse has been restrained, using the dominant hand, the 
tip of plastic pipette filled with PBS 1X is introduced in the vagina of the mouse and the liquid is flushed to 
collect the sample. 
 
Observe vaginal smears at 10x and 40x magnification. Using the 40x objective lens, 
the characterization of the cell types is easier; however, using the 10x objective lens, it is 
easier to characterize the estrous cycle phase based on the proportion of cell types present. 
Unstained slides of vaginal cells can be examined under the microscope3. This technique is 
called “wet smear” 2. Although the estrous cycle phase can be determined without staining 
the slides (Figure 5.7, right panels), the advantages of staining are better perception of the 
nucleus in the proestrus phase, more accurate identification of transition phases, and better 
pictures for publication. For routine and frequent evaluations we support the use of the “wet 
smear”.  
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Once the cells are collected, there are several staining techniques described in the 
literature for evaluation of these cells under the microscope. The classical Papanicolaou 
staining has been frequently used, allowing for discriminating the maturity of the nucleated 
epithelial cells. It is likewise useful to differentiate transition phases between proestrus and 
estrus. As an alternative, staining the vaginal smears can be simply achieved with 
methylene blue6 and some researchers also have recommended the use of the Cresyl violet 
staining4. In this chapter, we have addressed the reliability of the “wet smear” by 
comparing it with an alternative technique known as the May-Grünwald Giemsa protocol 
for staining vaginal smears (Figure 5.7). The May-Grünwald contains an acid dye, eosin, 
and a basic dye, the methylene blue; Giemsa solution is a mixture of methylene blue, eosin, 
and azure B. The epithelial cells are stained in pale beige, while their nuclei and leukocytes 
will be stained as violet-blue.   
5.2.3. Protocol: Staining vaginal smears with May-Grünwald Giemsa stain 
For stained slides, it is recommended to use a gelatin coated slide. It can be 
homemade following the protocol:  
- Prepare a 1% gelatin solution. Dissolve gelatin powder for 10 minutes in a 37oC 
water bath 
- Place slides on a flat surface 
- Put 1 or 2 drops of the 1% gelatin solution on the top of each slide 
- Spread the gelatin with a gloved finger   
- Dry slides on a flat surface and store them at 4oC 
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After collecting the vaginal cells according to the above protocol onto a gelatin-
coated slide, the smears are air dried for 30 to 40 minutes (or for a briefer interval at 37oC). 
Place the slides into a 100% methanol solution at -20oC for 5 minutes. Quickly air-dry the 
slides at room temperature. Cover the slides with 1:10 May-Grünwald* solution for 3 
minutes. Cover the slides with 1:5 Giemsa** staining solution for 5 minutes. Wash the 
slides in running tap water. Dry the slides at 37oC for 40 minutes. Observe vaginal smears 
at 10x (Figure 5.7, left panels) and 40x magnifications. 
* 9ml 100% methanol + 1ml May-Grünwald 0.25% (in 100% methanol) 
** Stock solution Giemsa 0.6%: 66 ml glycerine + 1g Giemsa, dissolve it at 45oC for 
30 minutes or longer if necessary; add 66 ml 100% methanol. Working solution Giemsa: 
38ml distilled water + 7 ml stock solution Giemsa 0.6% + 5ml 100% methanol. Staining 
solution Giemsa: 8 ml 100% methanol + 2 ml working solution Giemsa  
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Figure 5.7 : Comparison of stained versus unstained vaginal smears from the mouse estrous cycle. 
Slides on the left panel were air-dried and stained with May-Grünwald Giemsa, while those on the right were 
photographed unstained. Scale bars calibrate to 0.1 mm (magnification 100x). 
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